Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 212
Encontrada(s) 3 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

  • Quijada Álamo, Miguel
  • Hernández Sánchez, María
  • Alonso Pérez, Verónica
  • Rodríguez Vicente, Ana E.
  • García Tuñón, Ignacio
  • Martín Izquierdo, Marta
  • Hernández Sánchez, Jesús María
  • Herrero, Ana B.
  • Bastida, José María
  • San Segundo, Laura
  • Gruber, Michaela
  • García, Juan Luis
  • Yin, Shanye
  • Hacken, Elisa ten
  • Benito, Rocío
  • Ordóñez, José Luis
  • Wu, Catherine J.
  • Hernández-Rivas, Jesús María
The deletion of 11q (del(11q)) invariably comprises ATM gene in chronic lymphocytic leukemia (CLL). Concomitant mutations in this gene in the remaining allele have been identified in 1/3 of CLL cases harboring del(11q), being the biallelic loss of ATM associated with adverse prognosis. Although the introduction of targeted BCR inhibition has significantly favored the outcomes of del(11q) patients, responses of patients harboring ATM functional loss through biallelic inactivation are unexplored, and the development of resistances to targeted therapies have been increasingly reported, urging the need to explore novel therapeutic approaches. Here, we generated isogenic CLL cell lines harboring del(11q) and ATM mutations through CRISPR/Cas9-based gene-editing. With these models, we uncovered a novel therapeutic vulnerability of del(11q)/ ATM-mutated cells to dual BCR and PARP inhibition. Ex vivo studies in the presence of stromal stimulation on 38 CLL primary samples confirmed a synergistic action of the combination of olaparib and ibrutinib in del(11q)/ATM-mutated CLL patients. In addition, we showed that ibrutinib produced a homologous recombination repair impairment through RAD51 dysregulation, finding a synergistic link of both drugs in the DNA damage repair pathway. Our data provide a preclinical rationale for the use of this combination in CLL patients with this high-risk cytogenetic abnormality
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Opposite trends in the consumption of manufactured and roll-your-own cigarettes in Spain (1991-2020)

  • Fu, Marcela|||0000-0002-4962-0927
  • Martínez-Sánchez, José M.|||0000-0002-9632-5701
  • Clèries, Ramon|||0000-0002-3637-4747
  • Villalbí, Joan Ramón|||0000-0001-6915-2545
  • Daynard, Richard A.
  • Connolly, Gregory N.
  • Fernández, Esteve|||0000-0003-4239-723X
Objective: The aim of this study is to describe trends in the consumption of manufactured and roll-your-own cigarettes between 1991 and 2012 in Spain, and to project these trends up to 2020. Methods: We estimated daily consumption per capita during 1991-2012 using data on sales of manufactured cigarettes (20-packs) and rolling tobacco (kg) from the Tobacco Market Commission, and using data of the Spanish adult population from the National Statistics Institute. We considered different weights (0.5, 0.8 and 1 g) to compute the number of rolled cigarettes per capita. We computed the annual per cent of change and assessed possible changes in trends using joinpoint regression, and projected the consumption up to 2020 using Bayesian methods. Results: Daily consumption per capita of manufactured cigarettes decreased on average by 3.0% per year in 1991-2012, from 7.6 to 3.8 units, with three trend changes. However, daily consumption per capita of roll-your-own cigarettes increased on average by 14.1% per year, from 0.07 to 0.92 units of 0.5 g, with unchanged trends. Together, daily consumption per capita decreased between 2.9% and 2.5%, depending on the weight of the roll-your-own cigarettes. Projections up to 2020 indicate a decrease of manufactured cigarettes (1.75 units per capita) but an increase of roll-your-own cigarettes (1.25 units per capita). Conclusions: While the consumption per capita of manufactured cigarettes has decreased in the past years in Spain, the consumption of roll-your-own cigarettes has increased at an annual rate around 14% over the past years. Whereas a net decrease in cigarette consumption is expected in the future, use of roll-your-own cigarettes will continue to increase.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of the Spanish smoke-free legislation on adult, non-smoker exposure to secondhand smoke, Cross-sectional surveys before (2004) and after (2012) legislation

  • Sureda, Xisca|||0000-0002-6262-2257
  • Martínez-Sánchez, José M.|||0000-0002-9632-5701
  • Fu, Marcela|||0000-0002-4962-0927
  • Pérez Ortuño, Raúl|||0000-0002-1837-5447
  • Martínez, Cristina|||0000-0002-9368-1356
  • Carabasa, Esther
  • López Medina, María José|||0000-0003-4402-2239
  • Saltó, Esteve|||0000-0002-6739-8936
  • Pascual, José A.|||0000-0003-0837-4026
  • Fernández, Esteve|||0000-0003-4239-723X
Background: In 2006, Spain implemented a national smoke-free legislation that prohibited smoking in enclosed public places and workplaces (except in hospitality venues). In 2011, it was extended to all hospitality venues and selected outdoor areas (hospital campuses, educational centers, and playgrounds). The objective of the study is to evaluate changes in exposure to secondhand smoke among the adult non-smoking population before the first law (2004-05) and after the second law (2011-12). Methods: Repeated cross-sectional survey (2004-2005 and 2011-2012) of a representative sample of the adult (≥16 years) non-smoking population in Barcelona, Spain. We assess self-reported exposure to secondhand smoke (at home, the workplace, during leisure time, and in public/private transportation vehicles) and salivary cotinine concentration. Results: Overall, the self-reported exposure to secondhand smoke fell from 75.7% (95%CI: 72.6 to 78.8) in 2004-05 to 56.7% (95%CI: 53.4 to 60.0) in 2011-12. Self-reported exposure decreased from 32.5% to 27.6% (215.1%, p<0.05) in the home, from 42.9% to 37.5% (212.6%, p = 0.11) at work/education venues, from 61.3% to 38.9% (236.5%, p<0.001) during leisure time, and from 12.3% to 3.7% (269.9%, p<0.001) in public transportation vehicles. Overall, the geometric mean of the salivary cotinine concentration in adult non-smokers fell by 87.2%, from 0.93 ng/mL at baseline to 0.12 ng/mL after legislation (p<0.001). Conclusions: Secondhand smoke exposure among non-smokers, assessed both by self-reported exposure and salivary cotinine concentration, decreased after the implementation of a stepwise, comprehensive smoke-free legislation. There was a high reduction in secondhand smoke exposure during leisure time and no displacement of secondhand smoke exposure at home. © 2014 Sureda et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight, comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Davila-Batista, Veronica|||0000-0001-8888-395X
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier|||0000-0001-8569-861X
  • Tardón, Guillermo Fernández
  • Alguacil, Juan|||0000-0003-2703-9725
  • Vanaclocha Espí, Mercedes|||0000-0002-7202-2861
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Aragonés, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela|||0000-0001-9242-6364
  • Reguero Celada, Sofía
  • Pollán, Marina|||0000-0002-4328-1565
  • Martín, Vicente|||0000-0003-0552-2804
10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m 2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia

  • Navas-Acosta, Josgrey del Valle
  • Hernández-Sánchez, Alberto|||0000-0002-6601-3096
  • González, Teresa
  • Villaverde Ramiro, Ángela|||0000-0002-7337-7218
  • Santos, Sandra
  • Miguel, Cristina|||0000-0001-7359-7993
  • Ribera Salas, Jordi|||0000-0003-4796-6470
  • Granada, Isabel|||0000-0002-4275-0104
  • Morgades, Mireia|||0000-0003-0295-2534
  • Sánchez, Ricardo|||0000-0002-6383-0381
  • Such, Esperanza|||0000-0001-6892-403X
  • Barrena, Susana
  • Ciudad Pizarro, Juana
  • Dávila-Valls, Julio|||0000-0002-5185-2073
  • De las Heras, Natalia|||0000-0002-5188-5350
  • García-de Coca, Alfonso|||0000-0002-4942-060X
  • Labrador, Jorge|||0000-0002-3696-0287
  • Queizán, José Antonio
  • Martín, Sandra
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Benito, Rocío|||0000-0001-9781-4198
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
Adult B-cell acute lymphoblastic leukemia (B-ALL) is characterized by genetic heterogeneity and a high relapse rate, affecting over 40% of adults. However, the mechanisms leading to relapse in adults are poorly understood. Forty-four adult B-ALL patients were studied at both diagnosis and relapse by next-generation sequencing (NGS). Four main genetic pathways leading to relapse in adults were identified: IKZF1 genetic profile, RAS mutations and TP53 alterations in Ph-negative B-ALL and acquisition of ABL1 mutations in Ph-positive patients. The most frequently deleted gene at diagnosis was IKZF1 (52%), and 70% of these patients had IKZF1 profile. Notably, 88% of patients with IKZF1 at diagnosis retained this genetic profile at relapse. Conversely, the acquisition of RAS mutations or the expansion of subclones (normalized variant allele frequency < 25%) present from diagnosis were observed in 24% of Ph-negative patients at relapse. In addition, 24% of relapses in the Ph-negative cohort could potentially be driven by TP53 alterations. Of these cases, five presented from diagnosis, and four emerged at relapse, mostly as "double-hit" events involving both TP53 deletion and mutation. In Ph-positive B-ALL, the main genetic finding at relapse was the acquisition of ABL1 mutations (86%). Three clonal evolution patterns were identified: the persistent clone trajectory (25%), the expanding clone trajectory (11%) and the therapy-boosted trajectory (48%). Our results reveal the presence of preferential biological pathways leading to relapse in adult B-ALL. These findings underscore the need for personalized therapeutic strategies to improve clinical outcomes in adult patients with B-ALL.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Risk scores predicting disease progression in early-stage chronic lymphocytic leukemia, Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy

  • Arguello-Tomas, Miguel|||0000-0002-3329-4151
  • Mozas, Pablo|||0000-0001-9528-4971
  • Albiol, Nil|||0000-0003-2942-1362
  • López-Esteban, Miguel
  • Sierra, Jorge|||0000-0002-7966-0356
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Martínez-Laperche, Carolina
  • Moga, Esther|||0000-0003-4264-6910
  • Piñeyroa, Juan A.
  • Delgado, Julio|||0000-0002-5157-4376
  • Osorio, Santiago
  • Moreno, Carol|||0000-0003-3275-0271
Background: Overall, the prognosis of patients with chronic lymphocytic leukemia (CLL) in the early phase of the disease (Rai 0, Binet A) is favorable; some patients never require therapy. However, some patients require intervention shortly after diagnosis. In the past decade, several risk scores (RS) have been developed to predict disease progression, yet some patients are misclassified. On the other hand, IGHV subset 2 (IGHV2) predicts poor outcomes. Methods: A retrospective and multicentric study was conducted to compare the accuracy of five different RS (IPS-E, CR0, AIPS-E, CLL-IPI, and Barcelona-Brno) to predict disease progression in 781 stage A previously untreated patients with CLL. As an exploratory analysis, it was further investigated whether the inclusion of the IGHV2 as a poor prognostic parameter improved the accuracy of RS. Results: All the scores identified a similar group of patients with CLL in early stage with low-, intermediate-, and high-risk progression. Discrimination was high and similar in all RS (c-index = 0.74-0.79, area under the curve = 0.7-0.75), as well as calibration (p =.98) and parsimony, although CLL-IPI showed the best results (Akaike information criterion = 441). A total of 34.4% of patients were categorized within the same RS and concordance was at least moderate between RS. Conclusion: Moreover, the results suggest that IGHV2 may improve the accuracy of RS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia

  • Arguello-Tomas, Miguel|||0000-0002-3329-4151
  • Lynton-Pons, Elionor|||0000-0001-5375-7195
  • Albiol, Nil|||0000-0003-2942-1362
  • López Ferrer, Anna|||0000-0002-2121-963X
  • Sierra, Jorge|||0000-0002-7966-0356
  • Moga, Esther|||0000-0003-4264-6910
  • Moreno, Carol|||0000-0003-3275-0271
Background: Autoimmune disorders (AIDs) are frequent in patients with chronic lymphocytic leukemia (CLL). There is little information on the clinical characteristics and pathogenesis of nonhematologic AIDs in patients with CLL, although both entities present immunologic alterations in their clinical onset. Methods: This single-center series included 907 patients with CLL who had a median follow-up of 6.6 years (range, 0.1-36.4 years). Results: In total, 156 patients developed an AID, including 99 patients (10.9%) with nonhematologic AIDs, 46 (5.1%) with autoimmune cytopenia (AIC), and 11 (1.2%) with both; autoimmune hypothyroidism and psoriasis were the most frequent AIDs. Patients with nonhematologic AIDs had low-risk genetic features and were related to a better time to first treatment than patients with AIC (13.8 vs. 5.5 years; p <.001). Patients with both CLL and psoriasis had the lowest risk of progression. The authors performed a T-cell/natural killer-cell and cytokine assessment among patients who had CLL with and without psoriasis. An unsupervised hierarchical clustering revealed a distinct cluster characterized by an expansion of T-helper 17 cells, T-regulatory cells, interleukin-17F, and interleukin-23. Conclusions: The current findings suggest that nonhematologic AIDs are prevalent in patients with CLL, and these patients have a better prognosis than patients who have AIC. The expansion of interleukin-17F-producing cells in patients with psoriasis may explain their good prognosis.
Repisalud
Publication Artículo científico (JournalArticle)

Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project

  • Dierssen-Sotos, Trinidad
  • Palazuelos-Calderón, Camilo
  • Jimenez-Moleon, Jose J.
  • Aragones, Nuria
  • Altzibar, Jone M
  • Castaño-Vinyals, Gemma
  • Martín-Sánchez, Vicente
  • Gómez-Acebo, Inés
  • Guevara, Marcela
  • Tardón, Adonina
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Moreno, Victor
  • Molina, Antonio J
  • Alonso-Molero, Jéssica
  • Moreno-Iribas, Conchi
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
BACKGROUND: Reproductive factors are well known risk factors for breast cancer; however, little is known about how genetic variants in hormonal pathways interact with that relationship. METHODS: One thousand one hundred thirty nine cases of breast cancer in women and 1322 frequency-matched controls were compared. Genetic variants in hormonal pathways (identified in the Kyoto Encyclopedia of Genes and Genomes) were screened according to their relationship with breast cancer using the Cochran-Armitage statistic. Information on reproductive factors was obtained using a face-to-face questionnaire. The interaction among the selected genetic variants and reproductive factors was tested with logistic regression. RESULTS: Concerning C allele in rs2229712, compared to nulliparity in non-carriers the ORs for 1-2 and > 2 deliveries were 0.48 (0.28-0.81) and 0.34 (0.19-0.59), and in C carriers they were 0.92 (0.42-1.98) and 0.71 (0.31-1.61). Similar results were found in women carrying the C allele in rs1269851. Carriers of Allele T in rs35652107 and allele C in rs6018027 had the delivery number effect more pronounced. CONCLUSIONS: The number of deliveries had a dose-response protective effect on breast cancer; women carrying C allele in rs2229712 did not benefit from this protective effect.
Repisalud
Publication Artículo científico (JournalArticle)

Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer

  • Quintanal-Villalonga, Alvaro
  • Mediano, Mariló
  • Ferrer, Irene
  • Meléndez, Ricardo
  • Carranza-Carranza, Andrés
  • Suárez, Rocío
  • Carnero, Amancio
  • Molina-Pinelo, Sonia
  • Paz Ares, Luis Gonzaga
Lung tumors represent a major health problem. In early stage NSCLC tumors, surgical resection is the preferred treatment, but 30-55% of patients will relapse within 5 years after surgery. Thus, the identification of prognostic biomarkers in early stage NSCLC patients, especially those which are therapeutically addressable, is crucial to enhance survival of these patients. We determined the immunohistochemistry expression of key proteins involved in tumorigenesis and oncogenic signaling, p53, EGFR, pAKT and pERK, and correlated their expression level to clinicopathological characteristics and patient outcome. We found EGFR expression is higher in the squamous cell carcinomas than in adenocarcinomas (p=0.043), and that nuclear p53 staining correlated with lower differentiated squamous tumors (p=0.034). Regarding the prognostic potential of the expression of these proteins, high pERK levels proved to be an independent prognostic factor for overall (p<0.001) and progression-free survival (p<0.001) in adenocarcinoma patients, but not in those from the squamous histology, and high p53 nuclear levels were identified as independent prognostic factor for progression-free survival (p=0.031) only in squamous cell carcinoma patients. We propose a role as early prognostic biomarkers for pERK protein levels in adenocarcinoma, and for nuclear p53 levels in squamous cell lung carcinoma. The determination of these potential biomarkers in the adequate histologic context may predict the outcome of early stage NSCLC patients, and may offer a therapeutic opportunity to enhance survival of these patients.
Repisalud
Publication Artículo científico (JournalArticle)

Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus

  • Martinez, Isidoro
  • García-Carpizo, Verónica
  • Guijarro, Trinidad
  • Garcia-Gomez, Ana Belen
  • Navarro, Diego
  • Aranda, Ana
  • Zambrano, Alberto
Human respiratory syncytial virus (HRSV) accounts for the majority of lower respiratory tract infections during infancy and childhood and is associated with significant morbidity and mortality. HRSV provokes a proliferation arrest and characteristic syncytia in cellular systems such as immortalized epithelial cells. We show here that HRSV induces the expression of DNA damage markers and proliferation arrest such as P-TP53, P-ATM, CDKN1A and γH2AFX in cultured cells secondary to the production of mitochondrial reactive oxygen species (ROS). The DNA damage foci contained γH2AFX and TP53BP1, indicative of double-strand breaks (DSBs) and could be reversed by antioxidant treatments such as N-Acetylcysteine (NAC) or reduced glutathione ethyl ester (GSHee). The damage observed is associated with the accumulation of senescent cells, displaying a canonical senescent phenotype in both mononuclear cells and syncytia. In addition, we show signs of DNA damage and aging such as γH2AFX and CDKN2A expression in the respiratory epithelia of infected mice long after viral clearance. Altogether, these results show that HRSV triggers a DNA damage-mediated cellular senescence program probably mediated by oxidative stress. The results also suggest that this program might contribute to the physiopathology of the infection, tissue remodeling and aging, and might be associated to long-term consequences of HRSV infections.
Repisalud
Publication Artículo científico (JournalArticle)

α-Hispanolol Induces Apoptosis and Suppresses Migration and Invasion of Glioblastoma Cells Likely via Downregulation of MMP-2/9 Expression and p38MAPK Attenuation

  • Sanchez-Martin, Vanesa
  • Jimenez-Garcia, Lidia
  • Herranz, Sandra
  • Luque, Alfonso
  • Acebo, Paloma
  • Amesty, Ángel
  • Estévez-Braun, Ana
  • de Las Heras, Beatriz
  • Hortelano, Sonsoles
α-Hispanolol (α-H) is a labdane diterpenoid that has been shown to induce apoptosis in several human cancer cells. However, the effect of α-H in human glioblastoma cells has not been described. In the present work, we have investigated the effects of α-H on apoptosis, migration, and invasion of human glioblastoma cells with the aim of identifying the molecular targets underlying its mechanism of action. The results revealed that α-H showed significant cytotoxicity against human glioma cancer cell lines U87 and U373 in a concentration- and time-dependent manner. This effect was higher in U87 cells and linked to apoptosis, as revealed the increased percentage of sub-G1 population by cell cycle analysis and acquisition of typical features of apoptotic cell morphology. Apoptosis was also confirmed by significant presence of annexin V-positive cells and caspase activation. Pretreatment with caspase inhibitors diminishes the activities of caspase 8, 9, and 3 and maintains the percentage of viable glioblastoma cells, indicating that α-H induced cell apoptosis through both the extrinsic and the intrinsic pathways. Moreover, we also found that α-H downregulated the anti-apoptotic Bcl-2 and Bcl-xL proteins and activated the pro-apoptotic Bid and Bax proteins. On the other hand, α-H exhibited inhibitory effects on the migration and invasion of U87 cells in a concentration-dependent manner. Furthermore, additional experiments showed that α-H treatment reduced the enzymatic activities and protein levels of matrix metalloproteinase MMP-2 and MMP-9 and increased the expression of TIMP-1 inhibitor, probably via p38MAPK regulation. Finally, xenograft assays confirmed the anti-glioma efficacy of α-H. Taken together, these findings suggest that α-H may exert anti-tumoral effects in vitro and in vivo through the inhibition of cell proliferation and invasion as well as by the induction of apoptosis in human glioblastoma cells. This research describes α-H as a new drug that may improve the therapeutic efficacy against glioblastoma tumors.
Repisalud
Publication Artículo científico (JournalArticle)

Low adherence to the western and high adherence to the mediterranean dietary patterns could prevent colorectal cancer

  • Castelló Pastor, Adela
  • Amiano, Pilar
  • Fernandez de Larrea-Baz, Nerea
  • Martín, Vicente
  • Alonso, María Henar
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Olmedo-Requena, Rocío
  • Guevara, Marcela
  • Fernández-Tardón, Guillermo
  • Dierssen-Sotos, Trinidad
  • Llorens-Ivorra, Cristóbal
  • Huerta, José María
  • Capelo, Rocío
  • Fernández-Villa, Tania
  • Díez-Villanueva, Anna
  • Urtiaga, Carmen
  • Castilla Catalán, Jesús
  • Jimenez-Moleon, Jose J.
  • Moreno, Victor
  • Dávila-Batista, Verónica
  • Kogevinas, Manolis
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
PURPOSE: To assess if the associations found between three previously identified dietary patterns with breast, prostate and gastric cancer are also observed for colorectal cancer (CRC). METHODS: MCC-Spain is a multicase-control study that collected information of 1629 incident cases of CRC and 3509 population-based controls from 11 Spanish provinces. Western, Prudent and Mediterranean data-driven dietary patterns-derived in another Spanish case-control study-were reconstructed in MCC-Spain. Their association with CRC was assessed using mixed multivariable logistic regression models considering a possible interaction with sex. Risk by tumor site (proximal colon, distal colon, and rectum) was evaluated using multinomial regression models. RESULTS: While no effect of the Prudent pattern on CRC risk was observed, a high adherence to the Western dietary pattern was associated with increased CRC risk for both males [ORfourth(Q4) vs. first(Q1)quartile (95% CI): 1.45 (1.11;1.91)] and females [ORQ4 vs. Q1 (95% CI): 1.50 (1.07;2.09)] but seem to be confined to distal colon [ORfourth(Q4) vs. first(Q1)quartile (95% CI): 2.02 (1.44;2.84)] and rectal [ORQ4 vs. Q1 (95% CI): 1.46 (1.05;2.01)] tumors. The protective effect of the Mediterranean dietary pattern against CRC was observed for both sexes [males: ORQ4 vs. Q1 (95% CI): 0.71 (0.55;0.92); females: ORQ4 vs. Q1 (95% CI): 0.56 (0.40;0.77)] and for all cancer sites: proximal colon [ORQ4 vs. Q1 (95% CI): 0.70 (0.51;0.97)], distal colon [ORQ4 vs. Q1 (95% CI): 0.65 (0.48;0.89)], and rectum (ORQ4 vs. Q1 (95% CI): 0.60 (0.45;0.81)]. CONCLUSION: Our results are consistent with most of the associations previously found between these patterns and breast, prostate and gastric cancer risk and indicate that consuming whole fruits, vegetables, legumes, olive oil, nuts, and fish and avoiding red and processed meat, refined grains, sweets, caloric drinks, juices, convenience food, and sauces might reduce CRC risk.
Repisalud
Publication Artículo científico (JournalArticle)

Exposure to secondhand smoke in the home and mental health in children: a population-based study.

  • Padron-Monedero, Alicia
  • Galan, Iñaki
  • García-Esquinas, Esther
  • Fernández, Esteve
  • Ballbè, Montse
  • Rodríguez-Artalejo, Fernando
Objectives: To examine the association between exposure to secondhand smoke (SHS) in the home and mental health among children. Methods: Cross-sectional study of 2357 children representative of the Spanish population aged 4-12 years in 2011-2012. Duration of SHS exposure in children was reported by parents. Probable mental disorder was defined as a score>90th centile in the parental version of the Strengths and Difficulties Questionnaire (SDQ). Statistical analysis was performed with logistic regression and adjusted for sociodemographic variables, lifestyle, neighbourhood environment and family characteristics, including parental mental health. Results: Among study participants, 6.9% (95% CI 5.7% to 8.0%) were exposed to SHS in the home for <1 h/day and 4.5% (95% CI 3.5% to 5.5%) for ≥1 h/day. Compared to children not habitually exposed to SHS, the multivariate ORs for probable mental disorder were 1.49 (95% CI 0.85 to 2.62) for SHS exposure<1 h/day and 2.73 (95% CI 1.38 to 5.41) for SHS exposure≥1 h/day (p for linear trend=0.002). The corresponding ORs for attention-deficit and hyperactivity disorder (ADHD) were 2.18 (95% CI 1.30 to 3.64) for <1 h/day exposure and 3.14 (95% CI 1.63 to 6.04) for ≥1 h/day exposure (p for linear trend<0.001). No association was found between SHS and the rest of the components of the SDQ. Conclusions: Among children, SHS exposure in the home during ≥1 h/day is associated with a higher frequency of mental disorder. This association was mostly due to the impact of SHS on ADHD.
Repisalud
Publication Artículo científico (JournalArticle)

BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis

  • Richart, Laia
  • Carrillo-de-Santa-Pau, Enrique
  • Río-Machín, Ana
  • de Andrés, Mónica P
  • Cigudosa, Juan C
  • Lobo, Víctor J Sánchez-Arévalo
  • Real Arribas, Francisco
c-MYC oncogene is deregulated in most human tumours. Histone marks associated with transcriptionally active genes define high-affinity c-MYC targets. The mechanisms involved in their recognition by c-MYC are unknown. Here we report that c-MYC interacts with BPTF, a core subunit of the NURF chromatin-remodelling complex. BPTF is required for the activation of the full c-MYC transcriptional programme in fibroblasts. BPTF knockdown leads to decreased c-MYC recruitment to DNA and changes in chromatin accessibility. In Bptf-null MEFs, BPTF is necessary for c-MYC-driven proliferation, G1-S progression and replication stress, but not for c-MYC-driven apoptosis. Bioinformatics analyses unveil that BPTF levels correlate positively with c-MYC-driven transcriptional signatures. In vivo, Bptf inactivation in pre-neoplastic pancreatic acinar cells significantly delays tumour development and extends survival. Our findings uncover BPTF as a crucial c-MYC co-factor required for its biological activity and suggest that the BPTF-c-MYC axis is a potential therapeutic target in cancer.
Repisalud
Publication Artículo científico (JournalArticle)

Colorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study

  • Vallès, Xavier
  • Alonso, María Henar
  • López-Caleya, Juan Francisco
  • Díez-Obrero, Virginia
  • Dierssen-Sotos, Trinidad
  • Lope Carvajal, Virginia
  • Molina-Barceló, Ana
  • Chirlaque, María Dolores
  • Jimenez-Moleon, Jose J.
  • Fernández Tardón, Guillermo
  • Castilla Catalán, Jesús
  • Amiano, Pilar
  • Capelo, Rocío
  • Castaño-Vinyals, Gemma
  • Guinó, Elisabet
  • Molina de la Torre, Antonio José
  • Moreno-Iribas, Conchi
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Llorca, Javier
  • Martín, Vicente
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Moreno, Victor
OBJECTIVES: To explore the association of colorectal cancer with environmental solar radiation and sun exposure behavior, considering phenotypic variables (eye color, hair color and skin phenotype), dietary intake of vitamin D and calcium, and socio-demographic factors. STUDY DESIGN: Multicenter population-based frequency matched case-control study in Spain (MCC-Spain), with 2140 CRC cases and 3950 controls. METHODS: Data were obtained through personal interviews using a structured epidemiological questionnaire that included socio-demographic data, residential history, environmental exposures, behavior, phenotypic and dietary information. An environmental-lifetime sun exposure score was constructed combining residential history and average daily solar radiation, direct and diffuse. Logistic regression was used to explore the association between different variables. A structural equation model was used to verify the associations of the conceptual model. RESULTS: We found a lower risk of CRC in subjects frequently exposed to sunlight during the previous summer and skin burning due to sun exposure. No association was observed in relation to the residential solar radiation scores. Subjects with light eye or light hair colors had a lower risk of CRC that those with darker colors. Dietary calcium and vitamin D were also protective factors, but not in the multivariate model. The structural equation model analysis suggested that higher sun exposure was associated with a decreased risk of CRC, as well as dietary intake of calcium and vitamin D, and these factors are correlated among themselves and with environmental solar radiation and skin phenotypes. CONCLUSION: The results agree with previous observations that sun exposure, dietary vitamin D and calcium intake, and serum 25(OH)D concentration reduce the risk of CRC and indicate that these factors may be relevant for cancer prevention.
Repisalud
Publication Artículo científico (JournalArticle)

Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study)

  • Garcia-Saenz, Ariadna
  • Sánchez de Miguel, Alejandro
  • Espinosa, Ana
  • Valentin, Antonia
  • Aragones, Nuria
  • Llorca, Javier
  • Amiano, Pilar
  • Martín Sánchez, Vicente
  • Guevara, Marcela
  • Capelo, Rocío
  • Tardón, Adonina
  • Peiró-Pérez, Rosana
  • Jimenez-Moleon, Jose J.
  • Roca-Barceló, Aina
  • Perez-Gomez, Beatriz
  • Dierssen-Sotos, Trinidad
  • Fernández-Villa, Tania
  • Moreno-Iribas, Conchi
  • Moreno, Victor
  • García-Pérez, Javier
  • Castaño-Vinyals, Gemma
  • Pollan-Santamaria, Marina
  • Aubé, Martin
  • Kogevinas, Manolis
BACKGROUND: Night shift work, exposure to light at night (ALAN) and circadian disruption may increase the risk of hormone-dependent cancers. OBJECTIVES: We evaluated the association of exposure to ALAN during sleeping time with breast and prostate cancer in a population based multicase-control study (MCC-Spain), among subjects who had never worked at night. We evaluated chronotype, a characteristic that may relate to adaptation to light at night. METHODS: We enrolled 1,219 breast cancer cases, 1,385 female controls, 623 prostate cancer cases, and 879 male controls from 11 Spanish regions in 2008-2013. Indoor ALAN information was obtained through questionnaires. Outdoor ALAN was analyzed using images from the International Space Station (ISS) available for Barcelona and Madrid for 2012-2013, including data of remotely sensed upward light intensity and blue light spectrum information for each geocoded longest residence of each MCC-Spain subject. RESULTS: Among Barcelona and Madrid participants with information on both indoor and outdoor ALAN, exposure to outdoor ALAN in the blue light spectrum was associated with breast cancer [adjusted odds ratio (OR) for highest vs. lowest tertile, OR=1.47; 95% CI: 1.00, 2.17] and prostate cancer (OR=2.05; 95% CI: 1.38, 3.03). In contrast, those exposed to the highest versus lowest intensity of outdoor ALAN were more likely to be controls than cases, particularly for prostate cancer. Compared with those who reported sleeping in total darkness, men who slept in "quite illuminated" bedrooms had a higher risk of prostate cancer (OR=2.79; 95% CI: 1.55, 5.04), whereas women had a slightly lower risk of breast cancer (OR=0.77; 95% CI: 0.39, 1.51). CONCLUSION: Both prostate and breast cancer were associated with high estimated exposure to outdoor ALAN in the blue-enriched light spectrum. https://doi.org/10.1289/EHP1837.
Repisalud
Publication Artículo científico (JournalArticle)

Validating a breast cancer score in Spanish women. The MCC-Spain study

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Palazuelos, Camilo
  • Fernandez-Navarro, Pablo L
  • Altzibar, Jone M
  • González-Donquiles, Carmen
  • Ardanaz, Eva
  • Bustamante, Mariona
  • Alonso-Molero, Jéssica
  • Vidal, Carmen
  • Bayo-Calero, Juan
  • Tardón, Adonina
  • Salas, Dolores
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Rodríguez-Cundín, Paz
  • Vinyals, Gemma Castaño
  • Ederra, María
  • Vilorio-Marqués, Laura
  • Amiano, Pilar
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, 1,732 breast cancer cases and 1,910 controls were studied. The GRS92, modifiable and non-modifiable risk factor scores were estimated via logistic regression. SNPs without available genotyping were simulated as in the aforementioned 2016 study. The full model score was obtained by combining GRS92, modifiable and non-modifiable risk factor scores. Score performances were tested via the area under the ROC curve (AUROC), net reclassification index (NRI) and integrated discrimination improvement (IDI). Compared with non-modifiable and modifiable factor scores, GRS92 had higher discrimination power (AUROC: 0.6195, 0.5885 and 0.5214, respectively). Adding the non-modifiable factor score to GRS92 improved patient classification by 23.6% (NRI = 0.236), while the modifiable factor score only improved it by 7.2%. The full model AUROC reached 0.6244. A simulation study showed the ability of the full model for identifying women at high risk for breast cancer. In conclusion, a model combining genetic and risk factors can be used for stratifying women by their breast cancer risk, which can be applied to individualizing genetic counseling and screening recommendations.
Repisalud
Publication Artículo científico (JournalArticle)

Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spain

  • Rubín-García, María
  • Vitelli-Storelli, Facundo
  • Molina, Antonio José
  • Zamora-Ros, Raúl
  • Aragones, Nuria
  • Adarnaz, Eva
  • Castaño-Vinyals, Gemma
  • Obón-Santacana, Mireia
  • Gómez-Acebo, Inés
  • Molina-Barceló, Ana
  • Fernández-Tardón, Guillermo
  • Jimenez-Moleon, Jose J.
  • Alguacil, Juan
  • Chirlaque, María-Dolores
  • Toledo, Estefanía
  • Perez-Gomez, Beatriz
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Several anticancer properties have been largely attributed to phenolics in in vivo and in vitro studies, but epidemiologic evidence is still scarce. Furthermore, some classes have not been studied in relation to gastric cancer (GC). The aim of this study was to assess the relationship between the intake of phenolic acids, stilbenes, and other phenolics and the risk of developing GC and its anatomical and histological subtypes. We used data from a multi-case-control study (MCC-Spain) obtained from different regions of Spain. We included 2700 controls and 329 GC cases. Odds ratios (ORs) were calculated using mixed effects logistic regression considering quartiles of phenolic intake. Our results showed an inverse association between stilbene and lignan intake and GC risk (ORQ4 vs. Q1 = 0.47; 95% CI: 0.32-0.69 and ORQ4 vs. Q1 = 0.53; 95% CI: 0.36-0.77, respectively). We found no overall association between total phenolic acid and other polyphenol class intake and GC risk. However, hydroxybenzaldehydes (ORQ4 vs. Q1 = 0.41; 95% CI: 0.28-0.61), hydroxycoumarins (ORQ4 vs. Q1 = 0.49; 95% CI: 0.34-0.71), and tyrosols (ORQ4 vs. Q1 = 0.56; 95% CI: 0.39-0.80) were inversely associated with GC risk. No differences were found in the analysis by anatomical or histological subtypes. In conclusion, a diet high in stilbenes, lignans, hydroxybenzaldehydes, hydroxycoumarins, and tyrosols was associated with a lower GC risk. Further prospective studies are needed to confirm our results.
Repisalud
Publication Artículo científico (JournalArticle)

Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain)

  • García-Pérez, Javier
  • Lope Carvajal, Virginia
  • Perez-Gomez, Beatriz
  • Molina, Antonio José
  • Tardón, Adonina
  • Díaz Santos, María Angustias
  • Ardanaz, Eva
  • O'Callaghan-Gordo, Cristina
  • Altzibar, Jone M
  • Gómez-Acebo, Inés
  • Moreno, Victor
  • Peiró, Rosana
  • Marcos-Gragera, Rafael
  • Kogevinas, Manolis
  • Aragones, Nuria
  • Lopez-Abente, Gonzalo
  • Pollan-Santamaria, Marina
Breast cancer is the most frequent tumor in women worldwide, although well-established risk factors account for 53%-55% of cases. Therefore, other risk factors, including environmental exposures, may explain the remaining variation. Our objective was to assess the relationship between risk of breast cancer and residential proximity to industries, according to categories of industrial groups and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Using the current residence of cases and controls, this study was restricted to small administrative divisions, including both breast cancer cases (452) and controls (1511) in the 10 geographical areas recruiting breast cancer cases. Distances were calculated from the respective woman's residences to the 116 industries located in the study area. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (between 1 km and 3 km) to industrial plants, adjusting for matching variables and other confounders. Excess risk (OR; 95%CI) of breast cancer was found near industries overall (1.30; 1.00-1.69 at 3 km), particularly organic chemical industry (2.12; 1.20-3.76 at 2.5 km), food/beverage sector (1.87; 1.26-2.78 at 3 km), ceramic (4.71; 1.62-13.66 at 1.5 km), surface treatment with organic solvents (2.00; 1.23-3.24 at 3 km), and surface treatment of plastic and metals (1.51; 1.06-2.14 at 3 km). By pollutants, the excess risk (OR; 95%CI) was detected near industries releasing pesticides (2.09; 1.14-3.82 at 2 km), and dichloromethane (2.09; 1.28-3.40 at 3 km). Our results suggest a possible increased risk of breast cancer in women living near specific industrial plants and support the need for more detailed exposure assessment of certain agents released by these plants.
Repisalud
Publication Artículo científico (JournalArticle)

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

  • Ruiz Heredia, Yanira
  • Sanchez Vega, Beatriz
  • Onecha de La Fuente, Maria Esther
  • Barrio, Santiago
  • Alonso, Rafael
  • Martínez-Ávila, Jose Carlos
  • Cuenca, Isabel
  • Agirre, Xabier
  • Braggio, Esteban
  • Hernández, Miguel-T
  • Martínez, Rafael
  • Rosiñol, Laura
  • Gutierrez, Norma
  • Martin-Ramos, Marisa
  • Ocio, Enrique M
  • Echeveste, María-Asunción
  • de Oteyza, Jaime Pérez
  • Oriol, Albert
  • Bargay, Joan
  • Gironella, Mercedes
  • Ayala, Rosa
  • Bladé, Joan
  • Mateos, María-Victoria
  • Kortum, Klaus M
  • Stewart, Keith
  • García-Sanz, Ramón
  • Miguel, Jesús San
  • Lahuerta, Juan José
  • Martinez-Lopez, Joaquin
Repisalud
Publication Artículo científico (JournalArticle)

Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Palazuelos, Camilo
  • Fernandez-Navarro, Pablo L
  • Castaño-Vinyals, Gemma
  • Alonso-Molero, Jéssica
  • Urtiaga, Carmen
  • Fernández-Villa, Tania
  • Ardanaz, Eva
  • Rivas-Del-Fresno, Manuel
  • Molina-Barceló, Ana
  • Jimenez-Moleon, Jose J.
  • García-Martínez, Lidia
  • Amiano, Pilar
  • Rodríguez-Cundín, Paz
  • Moreno, Victor
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
INTRODUCTION: Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal. METHODS: We examined the association between the phototype and breast and prostate cancers using a Mendelian randomization analysis. We studied 1,738 incident cases of breast cancer and another 817 cases of prostate cancer. To perform a Mendelian randomization analysis on the phototype-cancer relationship, a genetic pigmentation score was required that met the following criteria: (1) the genetic pigmentation score was associated with phototype in controls; (2) the genetic pigmentation score was not associated with confounders in the relationship between phototype and cancer, and (3) the genetic pigmentation score was associated with cancer only through its association with phototype. Once this genetic score is available, the association between genetic pigmentation score and cancer can be identified as the association between phototype and cancer. RESULTS: The association between the genetic pigmentation score and phototype in controls showed that a higher genetic pigmentation score was associated with fair skin, blond hair, blue eyes and the presence of freckles. Applying the Mendelian randomization analysis, we verified that there was no association between the genetic pigmentation score and cancers of the breast and prostate. CONCLUSIONS: Phototype is not associated with breast or prostate cancer.
Repisalud
Publication Artículo científico (JournalArticle)

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

  • Mateo, F
  • Arenas, E J
  • Aguilar, H
  • Serra-Musach, J
  • de Garibay, G Ruiz
  • Boni, J
  • Maicas, M
  • Du, S
  • Iorio, F
  • Herranz-Ors, C
  • Islam, A
  • Prado, X
  • Llorente, A
  • Petit, A
  • Vidal, A
  • Català, I
  • Soler, T
  • Venturas, G
  • Rojo-Sebastian, A
  • Serra, H
  • Cuadras, D
  • Blanco, I
  • Lozano, J
  • Canals, F
  • Sieuwerts, A M
  • de Weerd, V
  • Look, M P
  • Puertas, S
  • García, N
  • Perkins, A S
  • Bonifaci, N
  • Skowron, M
  • Gómez-Baldó, L
  • Hernández, V
  • Martínez-Aranda, A
  • Martínez-Iniesta, M
  • Serrat, X
  • Cerón, J
  • Brunet, J
  • Barretina, M P
  • Gil, M
  • Falo, C
  • Fernández, A
  • Morilla, I
  • Pernas, S
  • Plà, M J
  • Andreu, X
  • Seguí, M A
  • Ballester, R
  • Castellà, E
  • Nellist, M
  • Morales, S
  • Valls, J
  • Velasco, A
  • Matias-Guiu, X
  • Figueras, A
  • Sánchez-Mut, J V
  • Sánchez-Céspedes, M
  • Cordero, A
  • Gómez-Miragaya, J
  • Palomero, L
  • Gómez, A
  • Gajewski, T F
  • Cohen, E E W
  • Jesiotr, M
  • Bodnar, L
  • Quintela-Fandino, M
  • López-Bigas, N
  • Valdés-Mas, R
  • Puente, X S
  • Viñals, F
  • Casanovas, O
  • Graupera, M
  • Hernández-Losa, J
  • Ramón Y Cajal, S
  • García-Alonso, L
  • Saez-Rodriguez, J
  • Esteller, M
  • Sierra, A
  • Martín-Martín, N
  • Matheu, A
  • Carracedo, A
  • González-Suárez, E
  • Nanjundan, M
  • Cortés, J
  • Lázaro, C
  • Odero, M D
  • Martens, J W M
  • Moreno-Bueno, G
  • Barcellos-Hoff, M H
  • Villanueva, A
  • Gomis, R R
  • Pujana, M A
Inhibitors of the mechanistic target of rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance to mTOR inhibition remains unknown. Here, complementary studies in human tumors, cancer models and cell lines reveal transcriptional reprogramming that supports metastasis in response to mTOR inhibition. This cancer feature is driven by EVI1 and SOX9. EVI1 functionally cooperates with and positively regulates SOX9, and promotes the transcriptional upregulation of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPARC). The expression of EVI1 and SOX9 is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR targeting failure.
Repisalud
Publication Artículo científico (JournalArticle)

Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

  • Walker, Logan C
  • Marquart, Louise
  • Pearson, John F
  • Wiggins, George A R
  • O'Mara, Tracy A
  • Parsons, Michael T
  • Barrowdale, Daniel
  • McGuffog, Lesley
  • Dennis, Joe
  • Benitez, Javier
  • Slavin, Thomas P
  • Radice, Paolo
  • Frost, Debra
  • Godwin, Andrew K
  • Meindl, Alfons
  • Schmutzler, Rita Katharina
  • Isaacs, Claudine
  • Peshkin, Beth N
  • Caldes, Trinidad
  • Hogervorst, Frans Bl
  • Lazaro, Conxi
  • Jakubowska, Anna
  • Montagna, Marco
  • Chen, Xiaoqing
  • Offit, Kenneth
  • Hulick, Peter J
  • Andrulis, Irene L
  • Lindblom, Annika
  • Nussbaum, Robert L
  • Nathanson, Katherine L
  • Chenevix-Trench, Georgia
  • Antoniou, Antonis C
  • Couch, Fergus J
  • Spurdle, Amanda B
Genome-wide studies of patients carrying pathogenic variants (mutations) in BRCA1 or BRCA2 have reported strong associations between single-nucleotide polymorphisms (SNPs) and cancer risk. To conduct the first genome-wide association analysis of copy-number variants (CNVs) with breast or ovarian cancer risk in a cohort of 2500 BRCA1 pathogenic variant carriers, CNV discovery was performed using multiple calling algorithms and Illumina 610k SNP array data from a previously published genome-wide association study. Our analysis, which focused on functionally disruptive genomic deletions overlapping gene regions, identified a number of loci associated with risk of breast or ovarian cancer for BRCA1 pathogenic variant carriers. Despite only including putative deletions called by at least two or more algorithms, detection of selected CNVs by ancillary molecular technologies only confirmed 40% of predicted common (>1% allele frequency) variants. These include four loci that were associated (unadjusted P<0.05) with breast cancer (GTF2H2, ZNF385B, NAALADL2 and PSG5), and two loci associated with ovarian cancer (CYP2A7 and OR2A1). An interesting finding from this study was an association of a validated CNV deletion at the CYP2A7 locus (19q13.2) with decreased ovarian cancer risk (relative risk=0.50, P=0.007). Genomic analysis found this deletion coincides with a region displaying strong regulatory potential in ovarian tissue, but not in breast epithelial cells. This study highlighted the need to verify CNVs in vitro, but also provides evidence that experimentally validated CNVs (with plausible biological consequences) can modify risk of breast or ovarian cancer in BRCA1 pathogenic variant carriers.
Repisalud
Publication Artículo científico (JournalArticle)

Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study

  • Casabonne, Delphine
  • Benavente, Yolanda
  • Robles, Claudia
  • Costas, Laura
  • Alonso, Esther
  • Gonzalez-Barca, Eva
  • Tardón, Adonina
  • Dierssen-Sotos, Trinidad
  • Vázquez, Eva Gimeno
  • Aymerich, Marta
  • Campo, Elias
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Juwana, Hedy
  • Middeldorp, Jaap
  • de Sanjose, Silvia
BACKGROUND: Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia. METHODS: Information on 150 cases with chronic lymphocytic leukemia and 157 frequency-matched (by age, sex and region) population-based controls from a Spanish multicentre case-control study was obtained. EBV immunoglobulin G serostatus was evaluated through a peptide-based ELISA and further by immunoblot analysis to EBV early antigens (EA), nuclear antigen (EBNA1), VCA-p18, VCA-p40 and Zebra. Two independent individuals categorized the serological patterns of the western blot analysis. Patients with very high response and diversity in EBV-specific polypeptides, in particular with clear responses to EA-associated proteins, were categorized as having an abnormal reactive pattern (ab_EBV). Adjusted odds ratios (OR) and 95% confidence interval (CI) were estimated using logistic regression models. RESULTS: Almost all subjects were EBV-IgG positive (>95% of cases and controls) whereas ab_EBV patterns were detected in 23% of cases (N = 34) and 11% of controls (N = 17; OR: 2.44, 95% CI, 1.29 to 4.62; P = 0.006), particularly in intermediate/high risk patients. Although based on small numbers, the association was modified by smoking with a gradual reduction of ab_EBV-related OR for all Rai stages from never smokers to current smokers. CONCLUSIONS: Highly distinct EBV antibody diversity patterns revealed by immunoblot analysis were detected in cases compared to controls, detectable at very early stages of the disease and particularly among non smokers. This study provides further evidence of an abnormal immunological response against EBV in patients with chronic lymphocytic leukemia.
Repisalud
Publication Artículo científico (JournalArticle)

CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia

  • Menezes, J
  • Makishima, H
  • Gomez, I
  • Acquadro, F
  • Gomez-Lopez, G.
  • Graña Castro, Osvaldo
  • Dopazo, Ana
  • Alvarez, S
  • Trujillo, M
  • Pisano, D G
  • Maciejewski, J P
  • Cigudosa, J C
Repisalud
Publication Artículo científico (JournalArticle)

Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results

  • Alonso-Molero, Jéssica
  • Molina, Antonio J
  • Jimenez-Moleon, Jose J.
  • Perez-Gomez, Beatriz
  • Martín, Vicente
  • Moreno, Victor
  • Amiano, Pilar
  • Ardanaz, Eva
  • de Sanjose, Silvia
  • Salcedo, Inmaculada
  • Fernández-Tardón, Guillermo
  • Alguacil, Juan
  • Salas, Dolores
  • Marcos-Gragera, Rafael
  • Chirlaque, María-Dolores
  • Aragones, Nuria
  • Castaño-Vinyals, Gemma
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
PURPOSE: Since 2016, the multicase-control study in Spain (MCC-Spain) has focused towards the identification of factors associated with cancer prognosis. Inception cohorts of patients with colorectal, breast and prostate cancers were assembled using the incident cases originally recruited. PARTICIPANTS: 2140 new cases of colorectal cancer, 1732 of breast cancer and 1112 of prostate cancer were initially recruited in 12 Spanish provinces; all cancers were incident and pathologically confirmed. Follow-up was obtained for 2097 (98%), 1685 (97%) and 1055 (94.9%) patients, respectively. FINDINGS TO DATE: Information gathered at recruitment included sociodemographic factors, medical history, lifestyle and environmental exposures. Biological samples were obtained, and 80% of patients were genotyped using a commercial exome array. The follow-up was performed by (1) reviewing medical records; (2) interviewing the patients by phone on quality of life; and (3) verifying vital status and cause of death in the Spanish National Death Index. Ninety-seven per cent of recruited patients were successfully followed up in 2017 or 2018; patient-years of follow-up were 30 914. Most colorectal cancers (52%) were at clinical stage II or lower at recruitment; 819 patients died in the follow-up and the 5-year survival was better for women (74.4%) than men (70.0%). 71% of breast cancers were diagnosed at stages I or II; 206 women with breast cancer died in the follow-up and the 5-year survival was 90.7%. 49% of prostate cancers were diagnosed at stage II and 32% at stage III; 119 patients with prostate cancer died in the follow-up and the 5-year survival was 93.7%. FUTURE PLANS: MCC-Spain has built three prospective cohorts on highly frequent cancers across Spain, allowing to investigate socioeconomic, clinical, lifestyle, environmental and genetic variables as putative prognosis factors determining survival of patients of the three cancers and the inter-relationship of these factors.
Repisalud
Publication Artículo científico (JournalArticle)

Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations

  • Martinez-Cruzado, Lucia
  • Tornin, Juan
  • Santos, Laura
  • Rodríguez, Aida
  • Garcia-Castro, Javier
  • Moris, Francisco
  • Rodriguez, Rene
Tumors evolve from initial tumorigenic events into increasingly aggressive behaviors in a process usually driven by subpopulations of cancer stem cells (CSCs). Mesenchymal stromal/stem cells (MSCs) may act as the cell-of-origin for sarcomas, and CSCs that present MSC features have been identified in sarcomas due to their ability to grow as self-renewed floating spheres (tumorspheres). Accordingly, we previously developed sarcoma models using human MSCs transformed with relevant oncogenic events. To study the evolution/emergence of CSC subpopulations during tumor progression, we compared the tumorigenic properties of bulk adherent cultures and tumorsphere-forming subpopulations both in the sarcoma cell-of-origin models (transformed MSCs) and in their corresponding tumor xenograft-derived cells. Tumor formation assays showed that the tumorsphere cultures from xenograft-derived cells, but not from the cell-of-origin models, were enriched in CSCs, providing evidence of the emergence of bona fide CSCs subpopulations during tumor progression. Relevant CSC-related factors, such as ALDH1 and SOX2, were increasingly upregulated in CSCs during tumor progression, and importantly, the increased levels and activity of ALDH1 in these subpopulations were associated with enhanced tumorigenicity. In addition to being a CSC marker, our findings indicate that ALDH1 could also be useful for tracking the malignant potential of CSC subpopulations during sarcoma evolution.
Repisalud
Publication Artículo científico antes de ser publicado, versión del autor (Preprint)

ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA

  • Talamillo, A
  • Grande, L
  • Ruiz-Ontañon, P
  • Velasquez, C
  • Mollinedo, P
  • Torices, S
  • Sánchez-Gómez, Pilar
  • Aznar, A
  • Esparis-Ogando, A
  • Lopez-Lopez, C
  • Lafita, C
  • Berciano, M T
  • Montero, J A
  • Vazquez-Barquero, A
  • Segura, V
  • Villagra, N T
  • Pandiella, A
  • Lafarga, Miguel
  • Leon, J
  • Martinez-Climent, J A
  • Sanz-Moreno, V
  • Fernandez-Luna, J L
Long-term survival remains low for most patients with glioblastoma (GBM), which reveals the need for markers of disease outcome and novel therapeutic targets. We describe that ODZ1 (also known as TENM1), a type II transmembrane protein involved in fetal brain development, plays a crucial role in the invasion of GBM cells. Differentiation of glioblastoma stem-like cells drives the nuclear translocation of an intracellular fragment of ODZ1 through proteolytic cleavage by signal peptide peptidase-like 2a. The intracellular fragment of ODZ1 promotes cytoskeletal remodelling of GBM cells and invasion of the surrounding environment both in vitro and in vivo. Absence of ODZ1 by gene deletion or downregulation of ODZ1 by small interfering RNAs drastically reduces the invasive capacity of GBM cells. This activity is mediated by an ODZ1-triggered transcriptional pathway, through the E-box binding Myc protein, that promotes the expression and activation of Ras homolog family member A (RhoA) and subsequent activation of Rho-associated, coiled-coil containing protein kinase (ROCK). Overexpression of ODZ1 in GBM cells reduced survival of xenografted mice. Consistently, analysis of 122 GBM tumour samples revealed that the number of ODZ1-positive cells inversely correlated with overall and progression-free survival. Our findings establish a novel marker of invading GBM cells and consequently a potential marker of disease progression and a therapeutic target in GBM.
Repisalud
Publication Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • de Pedro, María
  • Perez-Gomez, Beatriz
  • Servitja, Sonia
  • Moreno, Victor
  • Amiano, Pilar
  • Fernandez-Villa, Tania
  • Barricarte, Aurelio
  • Tardón, Adonina
  • Diaz-Santos, Marian
  • Peiró-Pérez, Rosana
  • Marcos-Gragera, Rafael
  • Lope Carvajal, Virginia
  • Gràcia-Lavedan, Esther
  • Alonso, María Henar
  • Michelena-Echeveste, Maria Jesus
  • Garcia-Palomo, Andrés
  • Guevara, Marcela
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
BACKGROUND: The relationship between non-steroidal antiinflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). METHODS: In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. RESULTS: In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. CONCLUSION: Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers.
Repisalud
Publication Artículo científico (JournalArticle)

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

  • Ferrer, Irene
  • Quintanal-Villalonga, Alvaro
  • Molina-Pinelo, Sonia
  • Garcia-Heredia, Jose Manuel
  • Perez, Marco
  • Suárez, Rocío
  • Ponce-Aix, Santiago
  • Paz Ares , Luis Gonzaga
  • Carnero, Amancio
BACKGROUND: The high incidence and mortality of lung tumours is a major health problem. Therefore, the identification both of biomarkers predicting efficacy for therapies in use and of novel efficacious therapeutic agents is crucial to increase patient survival. MAP17 (PDZK1IP1) is a small membrane-bound protein whose upregulation is reported as a common feature in tumours from diverse histological origins. Furthermore, MAP17 is correlated with tumour progression. METHODS: We assessed the expression of MAP17 in preclinical models, including cell lines and patient-derived xenografts (PDXs), assessing its correlation with sensitivity to different standard-of-care drugs in lung adenocarcinoma, as well as novel drugs. At the clinical level, we subsequently correlated MAP17 expression in human tumours with patient response to these therapies. RESULTS: We show that MAP17 expression is induced during lung tumourigenesis, particularly in lung adenocarcinomas, and provide in vitro and in vivo evidence that MAP17 levels predict sensitivity to therapies currently under clinical use in adenocarcinoma tumours, including cisplatin, carboplatin and EGFR inhibitors. In addition, we show that MAP17 expression predicts proteasome inhibitor efficacy in this context and that bortezomib, an FDA-approved drug, may be a novel therapeutic approach for MAP17-overexpressing lung adenocarcinomas. CONCLUSIONS: Our results indicate a potential prognostic role for MAP17 in lung tumours, with particular relevance in lung adenocarcinomas, and highlight the predictive pot0065ntial of this membrane-associated protein for platinum-based therapy and EGFR inhibitor efficacy. Furthermore, we propose bortezomib treatment as a novel and efficacious therapy for lung adenocarcinomas exhibiting high MAP17 expression.
Repisalud
Publication Artículo científico (JournalArticle)

RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models

  • Gambera, Stefano
  • Patiño-García, Ana
  • Alfranca, Arantzazu
  • Garcia-Castro, Javier
Osteosarcoma (OS) is a highly aggressive tumor characterized by malignant cells producing pathologic bone; the disease presents a natural tendency to metastasize. Genetic studies indicate that the OS genome is extremely complex, presenting signs of macro-evolution, and linear and branched patterns of clonal development. However, those studies were based on the phylogenetic reconstruction of next-generation sequencing (NGS) data, which present important limitations. Thus, testing clonal evolution in experimental models could be useful for validating this hypothesis. In the present study, lentiviral LeGO-vectors were employed to generate colorimetric red, green, blue (RGB)-marking in murine, canine, and human OS. With this strategy, we studied tumor heterogeneity and the clonal dynamics occurring in vivo in immunodeficient NOD.Cg-Prkdcscid-Il2rgtm1Wjl/SzJ (NSG) mice. Based on colorimetric label, tumor clonal composition was analyzed by confocal microscopy, flow cytometry, and different types of supervised and unsupervised clonal analyses. With this approach, we observed a consistent reduction in the clonal composition of RGB-marked tumors and identified evident clonal selection at the first passage in immunodeficient mice. Furthermore, we also demonstrated that OS could follow a neutral model of growth, where the disease is defined by the coexistence of different tumor sub-clones. Our study demonstrates the importance of rigorous testing of the selective forces in commonly used experimental models.
Repisalud
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Repisalud
Publication Artículo científico (JournalArticle)

Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma

  • Gonzalez-Gomez, Pilar
  • Crecente-Campo, Jose
  • Zahonero, Cristina
  • Fuente, Maria de la
  • Hernández-Laín, Aurelio
  • Mira, Helena
  • Sánchez-Gómez, Pilar
  • Garcia-Fuentes, Marcos
Glioblastoma tumor initiating cells are believed to be the main drivers behind tumor recurrence, and therefore therapies that specifically manage this population are of great medical interest. In a previous work, we synthesized controlled release microspheres optimized for intracranial delivery of BMP7, and showed that these devices are able to stop the in vitro growth of a glioma cell line. Towards the translational development of this technology, we now explore these microspheres in further detail and characterize the mechanism of action and the in vivo therapeutic potential using tumor models relevant for the clinical setting: human primary glioblastoma cell lines. Our results show that BMP7 can stop the proliferation and block the self-renewal capacity of those primary cell lines that express the receptor BMPR1B. BMP7 was encapsulated in poly (lactic-co-glycolic acid) microspheres in the form of a complex with heparin and Tetronic, and the formulation provided effective release for several weeks, a process controlled by carrier degradation. Data from xenografts confirmed reduced and delayed tumor formation for animals treated with BMP7-loaded microspheres. This effect was coincident with the activation of the canonical BMP signaling pathway. Importantly, tumors treated with BMP7-loaded microspheres also showed downregulation of several markers that may be related to a malignant stem cell-like phenotype: CD133(+), Olig2, and GFAPδ. We also observed that tumors treated with BMP7-loaded microspheres showed enhanced expression of cell cycle inhibitors and reduced expression of the proliferation marker PCNA. In summary, BMP7-loaded controlled release microspheres are able to inhibit GBM growth and reduce malignancy markers. We envisage that this kind of selective therapy for tumor initiating cells could have a synergistic effect in combination with conventional cytoreductive therapy (chemo-, radiotherapy) or with immunotherapy.
Repisalud
Publication Artículo científico (JournalArticle)

NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells

  • Urso, Katia
  • Fernández Gil, Andrés
  • Velasco, Patricia
  • Cotrina, Javier
  • Andres, Belen de
  • Sánchez-Gómez, Pilar
  • Hernández-Laín, Aurelio
  • Hortelano, Sonsoles
  • Redondo, Juan Miguel
  • Cano, Eva
Calcium/Calcineurin/Nuclear Factor of Activated T cells (Ca/CN/NFAT) signalling pathway is the main calcium (Ca2+) dependent signalling pathway involved in the homeostasis of brain tissue. Here, we study the presence of NFATc members in human glioma by using U251 cells and a collection of primary human glioblastoma (hGB) cell lines. We show that NFATc3 member is the predominant member. Furthermore, by using constitutive active NFATc3 mutant and shRNA lentiviral vectors to achieve specific silencing of this NFATc member, we describe cytokines and molecules regulated by this pathway which are required for the normal biology of cancer cells. Implanting U251 in an orthotopic intracranial assay, we show that specific NFATc3 silencing has a role in tumour growth. In addition NFATc3 knock-down affects both the proliferation and migration capacities of glioma cells in vitro. Our data open the possibility of NFATc3 as a target for the treatment of glioma.
Repisalud
Publication Artículo científico (JournalArticle)

c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells

  • Abarrategi, Ander
  • Gambera, Stefano
  • Alfranca, Arantzazu
  • Rodriguez-Milla, Miguel A
  • Perez-Tavarez, Raquel
  • Rouault-Pierre, Kevin
  • Waclawiczek, Alexander
  • Chakravarty, Probir
  • Mulero, Francisca
  • Trigueros, César
  • Navarro, Samuel
  • Bonnet, Dominique
  • Garcia-Castro, Javier
Mesenchymal progenitor cells (MPCs) have been hypothesized as cells of origin for sarcomas, and c-Fos transcription factor has been showed to act as an oncogene in bone tumors. In this study, we show c-Fos is present in most sarcomas with chondral phenotype, while multiple other genes are related to c-Fos expression pattern. To further define the role of c-Fos in sarcomagenesis, we expressed it in primary human MPCs (hMPCs), immortalized hMPCs and transformed murine MPCs (mMPCs). In immortalized hMPCs, c-Fos expression generated morphological changes, reduced mobility capacity and impaired adipogenic- and osteogenic-differentiation potentials. Remarkably, immortalized hMPCs or mMPCs expressing c-Fos generated tumors harboring a chondrogenic phenotype and morphology. Thus, here we show that c-Fos protein has a key role in sarcomas and that c-Fos expression in immortalized MPCs yields cell transformation and chondrogenic tumor formation.
Repisalud
Publication Artículo científico (JournalArticle)

The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription through Cooperation between the Transcription Factors Oct1 and RUNX1

  • Gomez Fontela, Miguel
  • Notario, Laura
  • Alari-Pahissa, Elisenda
  • Lorente, Elena
  • Lauzurica, Pilar
The immune regulatory receptor CD69 is expressed upon activation in all types of leukocytes and is strongly regulated at the transcriptional level. We previously described that, in addition to the CD69 promoter, there are four conserved noncoding regions (CNS1-4) upstream of the CD69 promoter. Furthermore, we proposed that CNS2 is the main enhancer of CD69 transcription. In the present study, we mapped the transcription factor (TF) binding sites (TFBS) from ChIP-seq databases within CNS2. Through luciferase reporter assays, we defined a ~60 bp sequence that acts as the minimum enhancer core of mouse CNS2, which includes the Oct1 TFBS. This enhancer core establishes cooperative interactions with the 3' and 5' flanking regions, which contain RUNX1 BS. In agreement with the luciferase reporter data, the inhibition of RUNX1 and Oct1 TF expression by siRNA suggests that they synergistically enhance endogenous CD69 gene transcription. In summary, we describe an enhancer core containing RUNX1 and Oct1 BS that is important for the activity of the most potent CD69 gene transcription enhancer.
Repisalud
Publication Artículo científico (JournalArticle)

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction

  • Quintanal-Villalonga, Alvaro
  • Ojeda-Marquez, Laura
  • Marrugal, Ángela
  • Yagüe, Patricia
  • Ponce-Aix, Santiago
  • Salinas, Ana
  • Carnero, Amancio
  • Ferrer, Irene
  • Molina-Pinelo, Sonia
  • Paz Ares , Luis Gonzaga
The FGFR4-388Arg variant has been related to poor prognosis in several types of cancer, including lung cancer. The mechanism underlying this association has not been addressed in detail in patients with this pathology. Here, we report that this FGFR4 variant induces MAPK and STAT3 activation and causes pro-oncogenic effects in NSCLC in vitro and in vivo. This variant induces the expression of EMT-related genes, such as N-cadherin, vimentin, Snail1 and Twist1. Indeed, the induction of N-cadherin protein expression by this variant is essential for its pro-tumorigenic role. The presence of the FGFR4-388Arg variant correlates with higher N-cadherin expression levels in clinical NSCLC samples and with poorer outcome in patients with FGFR expression. These results support the prognostic role of this FGFR variant in lung cancer and show that these effects may be mediated by the induction of N-cadherin expression and an EMT phenotype.
Repisalud
Publication Artículo científico (JournalArticle)

Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

  • Hernandez-SanMiguel, Esther
  • Gargini, Ricardo
  • Cejalvo, Teresa
  • Segura-Collar, Berta
  • Nuñez-Hervada, Paula
  • Hortigüela, Rafael
  • Sepúlveda-Sánchez, Juan Manuel
  • Hernández-Laín, Aurelio
  • Pérez-Núñez, Ángel
  • Sanz, Eduardo
  • Sánchez-Gómez, Pilar
Glioblastoma (GBM) is the most common and devastating primary brain tumor. The presence of cancer stem cells (CSCs) has been linked to their therapy resistance. Molecular and cellular components of the tumor microenvironment also play a fundamental role in the aggressiveness of these tumors. In particular, high levels of hypoxia and reactive oxygen species participate in several aspects of GBM biology. Moreover, GBM contains a large number of macrophages, which normally behave as immunosuppressive tumor-supportive cells. In fact, the presence of both, hypoxia and M2-like macrophages, correlates with malignancy and poor prognosis in gliomas. Antioxidant agents, as nutritional supplements, might have antitumor activity. Ocoxin® oral solution (OOS), in particular, has anti-inflammatory and antioxidant properties, as well as antitumor properties in several neoplasia, without known side effects. Here, we describe how OOS affects stem cell properties in certain GBMs, slowing down their tumor growth. In parallel, OOS has a direct effect on macrophage polarization in vitro and in vivo, inhibiting the protumoral features of M2 macrophages. Therefore, OOS could be a feasible candidate to be used in combination therapies during GBM treatment because it can target the highly resilient CSCs as well as their supportive immune microenvironment, without adding toxicity to conventional treatments.
Repisalud
Publication Artículo científico (JournalArticle)

EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma

  • Cidre-Aranaz, Florencia
  • Grünewald, Thomas G P
  • Surdez, D
  • Garcia-Garcia, Laura
  • Carlos Lázaro, J
  • Kirchner, T
  • Gonzalez-Gonzalez, Laura
  • Sastre, A
  • García-Miguel, P
  • López-Pérez, S E
  • Monzon-Fernandez, Sara
  • Delattre, O
  • Alonso, Javier
Ewing sarcoma is characterized by chromosomal translocations fusing the EWS gene with various members of the ETS family of transcription factors, most commonly FLI1. EWS-FLI1 is an aberrant transcription factor driving Ewing sarcoma tumorigenesis by either transcriptionally inducing or repressing specific target genes. Herein, we showed that Sprouty 1 (SPRY1), which is a physiological negative feedback inhibitor downstream of fibroblast growth factor (FGF) receptors (FGFRs) and other RAS-activating receptors, is an EWS-FLI1 repressed gene. EWS-FLI1 knockdown specifically increased the expression of SPRY1, while other Sprouty family members remained unaffected. Analysis of SPRY1 expression in a panel of Ewing sarcoma cells showed that SPRY1 was not expressed in Ewing sarcoma cell lines, suggesting that it could act as a tumor suppressor gene in these cells. In agreement, induction of SPRY1 in three different Ewing sarcoma cell lines functionally impaired proliferation, clonogenic growth and migration. In addition, SPRY1 expression inhibited extracellular signal-related kinase/mitogen-activated protein kinase (MAPK) signaling induced by serum and basic FGF (bFGF). Moreover, treatment of Ewing sarcoma cells with the potent FGFR inhibitor PD-173074 reduced bFGF-induced proliferation, colony formation and in vivo tumor growth in a dose-dependent manner, thus mimicking SPRY1 activity in Ewing sarcoma cells. Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort. Taken together, our data indicate that EWS-FLI1-mediated repression of SPRY1 leads to unrestrained bFGF-induced cell proliferation, suggesting that targeting the FGFR/MAPK pathway can constitute a promising therapeutic approach for this devastating disease.
Repisalud
Publication Artículo científico (JournalArticle)

The Dietary Inflammatory Index and Chronic Lymphocytic Leukaemia in the MCC Spain Study

  • Flores, José Carlos
  • Gràcia-Lavedan, Esther
  • Benavente, Yolanda
  • Amiano, Pilar
  • Romaguera, Dora
  • Costas, Laura
  • Robles, Claudia
  • Gonzalez-Barca, Eva
  • de la Banda, Esmeralda
  • Alonso, Esther
  • Aymerich, Marta
  • Campo, Elias
  • Dierssen-Sotos, Trinidad
  • Marcos-Gragera, Rafael
  • Rodríguez-Suárez, Marta María
  • Solans, Marta
  • Gimeno, Eva
  • Garcia Martin, Paloma
  • Aragones, Nuria
  • Shivappa, Nitin
  • Hebert, James R
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • de Sanjose, Silvia
  • Castaño-Vinyals, Gemma
  • Casabonne, Delphine
Chronic inflammation plays a role in the development of chronic lymphocytic leukaemia (CLL), and diet might modulate chronic inflammation. This study aims to evaluate the association between the dietary inflammatory index (DII®) and CLL. A total of 366 CLL cases and 1643 controls of the Spanish multicase-control (MCC) Spain study were included. The inflammatory potential of the diet was assessed using the energy-adjusted dietary inflammatory index (E-DII) based on 30 items from a validated semi-quantitative food frequency questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression models controlling for potential confounders. Overall, a modest, non-statistically significant, positive association was observed between CLL and E-DII scores (OR for a one-unit increase in E-DII: 1.05 (CI 95%: 0.99, 1.12), p-value = 0.09 and by tertiles: ORT2vsT1: 1.20 (CI 95%: 0.90, 1.59); OR T3vsT1: 1.21 (CI 95%: 0.90, 1.62), p trend = 0.21). These results were independent from disease severity (p-het: 0.70), time from diagnosis (p-het: 0.67) and CLL treatment received (p-het: 0.56). No interactions were detected. In conclusion, the consumption of a diet with high pro-inflammatory components was not significantly associated with CLL. Changes towards a more pro-inflammatory dietary pattern in younger generations not included here warrant future research.
Repisalud
Publication Artículo científico (JournalArticle)

Shoc2/Sur8 Protein Regulates Neurite Outgrowth

  • Leon-Espinosa, Gonzalo
  • Sanchez-Ruiloba, Lucia
  • Perez-Rodriguez, Andrea
  • Gragera, Teresa
  • Martinez, Natalia
  • Hernandez, Silvia
  • Anta-Felez, Berta
  • Calero, Olga
  • Garcia-Dominguez, Carlota A
  • Dura, Lara M
  • Peña-Jimenez, Daniel
  • Castro, Judith
  • Zarich-Dimitrievich, Natasha
  • Sánchez-Gómez, Pilar
  • Calero, Miguel
  • Iglesias, Teresa
  • Oliva-Martinez, Jose Luis
  • Rojas-Cabañeros, Jose Maria
The Shoc2 protein has been implicated in the positive regulation of the Ras-ERK pathway by increasing the functional binding interaction between Ras and Raf, leading to increased ERK activity. Here we found that Shoc2 overexpression induced sustained ERK phosphorylation, notably in the case of EGF stimulation, and Shoc2 knockdown inhibited ERK activation. We demonstrate that ectopic overexpression of human Shoc2 in PC12 cells significantly promotes neurite extension in the presence of EGF, a stimulus that induces proliferation rather than differentiation in these cells. Finally, Shoc2 depletion reduces both NGF-induced neurite outgrowth and ERK activation in PC12 cells. Our data indicate that Shoc2 is essential to modulate the Ras-ERK signaling outcome in cell differentiation processes involved in neurite outgrowth.
Repisalud
Publication Artículo científico (JournalArticle)

Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study)

  • Obón-Santacana, Mireia
  • Romaguera, Dora
  • Gràcia-Lavedan, Esther
  • Molinuevo, Amaia
  • Molina-Montes, Esther
  • Shivappa, Nitin
  • Hebert, James R
  • Tardón, Adonina
  • Castaño-Vinyals, Gemma
  • Moratalla, Ferran
  • Guinó, Elisabet
  • Marcos-Gragera, Rafael
  • Azpiri, Mikel
  • Gil, Leire
  • Olmedo-Requena, Rocío
  • Lozano-Lorca, Macarena
  • Alguacil, Juan
  • Fernández-Villa, Tania
  • Martín, Vicente
  • Molina, Antonio J
  • Ederra, María
  • Moreno-Iribas, Conchi
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Castelló Pastor, Adela
  • Huerta, José María
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Molina-Barceló, Ana
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Moreno, Victor
  • Amiano, Pilar
Inflammation and antioxidant capacity have been associated with colorectal and breast cancer. We computed the dietary inflammatory index (DII®), and the total dietary non-enzymatic antioxidant capacity (NEAC) and associated them with colorectal and breast cancer risk in the population-based multi case-control study in Spain (MCC-Spain). We included 1852 colorectal cancer and 1567 breast cancer cases, and 3447 and 1486 population controls, respectively. DII score and NEAC were derived using data from a semi-quantitative validated food frequency questionnaire. Unconditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) for energy-adjusted DII (E-DII), and a score combining E-DII and NEAC. E-DII was associated with colorectal cancer risk (OR = 1.93, highest quartile versus lowest, 95%CI:1.60-2.32; p-trend: <0.001); this increase was observed for both colon and rectal cancer. Less pronounced increased risks were observed for breast cancer (OR = 1.22, highest quartile versus lowest, 95%CI:0.99-1.52, p-trend: >0.10). The combined score of high E-DII scores and low antioxidant values were associated with colorectal cancer risk (OR = 1.48, highest quartile versus lowest, 95%CI: 1.26-1.74; p-trend: <0.001), but not breast cancer. This study provides evidence that a pro-inflammatory diet is associated with increased colorectal cancer risk while findings for breast cancer were less consistent.
Repisalud
Publication Artículo científico (JournalArticle)

Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study

  • Solans, Marta
  • Castelló Pastor, Adela
  • Benavente, Yolanda
  • Marcos-Gragera, Rafael
  • Amiano, Pilar
  • Gràcia-Lavedan, Esther
  • Costas, Laura
  • Robles, Claudia
  • Gonzalez-Barca, Eva
  • de la Banda, Esmeralda
  • Alonso, Esther
  • Aymerich, Marta
  • Campo, Elias
  • Dierssen-Sotos, Trinidad
  • Fernández-Tardón, Guillermo
  • Olmedo-Requena, Rocío
  • Gimeno, Eva
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • de Sanjose, Silvia
  • Pollan-Santamaria, Marina
  • Casabonne, Delphine
Diet is a modifiable risk factor for several neoplasms but evidence for chronic lymphocytic leukemia (CLL) is sparse. Previous studies examining the association between single-food items and CLL risk have yielded mixed results, while few studies have been conducted on overall diet, reporting inconclusive findings. This study aimed to evaluate the association between adherence to three dietary patterns and CLL in the multicase-control study (MCC-Spain) study. Anthropometric, sociodemographic, medical and dietary information was collected for 369 CLL cases and 1605 controls. Three validated dietary patterns, Western, Prudent and Mediterranean, were reconstructed in the MCC-Spain data. The association between adherence to each dietary pattern and CLL was assessed, overall and by Rai stage, using mixed logistic regression models adjusted for potential confounders. High adherence to a Western dietary pattern (i.e. high intake of high-fat dairy products, processed meat, refined grains, sweets, caloric drinks, and convenience food) was associated with CLL [ORQ4 vs. Q1=1.63 (95%CI 1.11; 2.39); P-trend=0.02; OR 1-SD increase=1.19 (95%CI: 1.03; 1.37)], independently of Rai stages. No differences in the association were observed according to sex, Body Mass Index, energy intake, tobacco, physical activity, working on a farm, or family history of hematologic malignancies. No associations were observed for Mediterranean and Prudent dietary patterns and CLL. This study provides the first evidence for an association between a Western dietary pattern and CLL, suggesting that a proportion of CLL cases could be prevented by modifying dietary habits. Further research, especially with a prospective design, is warranted to confirm these findings.
Repisalud
Publication Artículo científico (JournalArticle)

Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

  • Peremiquel-Trillas, Paula
  • Benavente, Yolanda
  • Martín-Bustamante, Mayte
  • Casabonne, Delphine
  • Perez-Gomez, Beatriz
  • Gómez-Acebo, Inés
  • Oliete-Canela, Anna
  • Diéguez-Rodríguez, Marta
  • Tusquets, Ignasi
  • Amiano, Pilar
  • Mengual, Lourdes
  • Ardanaz, Eva
  • Capelo, Rocío
  • Molina de la Torre, Antonio J
  • Salas-Trejo, Dolores
  • Fernández-Tardón, Guillermo
  • Lope Carvajal, Virginia
  • Jimenez-Moleon, Jose J.
  • Marcos-Gragera, Rafael
  • Dierssen-Sotos, Trinidad
  • Azpiri, Mikel
  • Muñoz, Montse
  • Guevara, Marcela
  • Fernández-Villa, Tania
  • Molina-Barceló, Ana
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Castaño-Vinyals, Gemma
  • Alguacil, Juan
  • Kogevinas, Manolis
  • de Sanjose, Silvia
  • Costas, Laura
BACKGROUND: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compounds on human health. OBJECTIVES: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast and prostate cancer. METHODS: We carried out a population-based case-control study including 1513 incident cases of breast cancer, 1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered different scenarios of exposure and different subtypes of alkylphenolic compounds. RESULTS: History of occupational exposure to alkylphenolic compounds was modestly associated with breast cancer (OR = 1.23; 95% CI = 1.01-1.48). Within the different scenarios, the occupational use of domestic tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02-1.60), while occupational exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to nonylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00-1.47), while exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic compounds and prostate cancer, except for a positive association among men occupationally exposed to cosmetic, hair and personal hygiene products. CONCLUSIONS: Our findings suggest a modest association between breast cancer risk and occupational exposure to alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These findings warrant further corroboration in other studies.
Repisalud
Publication Artículo científico (JournalArticle)

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

  • Zahonero, Cristina
  • Aguilera, Pilar
  • Ramírez-Castillejo, Carmen
  • Pajares, Marta
  • Bolos, Victoria
  • Cantero, Diana
  • Pérez-Núñez, Ángel
  • Hernández-Laín, Aurelio
  • Sánchez-Gómez, Pilar
  • Sepúlveda, Juan Manuel
Glioblastomas (GBM) are devastating tumors in which there has been little clinical improvement in the last decades. New molecularly directed therapies are under development. EGFR is one of the most promising targets, as this receptor is mutated and/or overexpressed in nearly half of the GBMs. However, the results obtained with first-generation tyrosine-kinase inhibitors have been disappointing with no clear predictive markers of tumor response. Here, we have tested the antitumoral efficacy of a second-generation inhibitor, dacomitinib (PF299804, Pfizer), that binds in an irreversible way to the receptor. Our results confirm that dacomitinib has an effect on cell viability, self-renewal, and proliferation in EGFR-amplified ± EGFRvIII GBM cells. Moreover, systemic administration of dacomitinib strongly impaired the in vivo tumor growth rate of these EGFR-amplified cell lines, with a decrease in the expression of stem cell-related markers. However, continuous administration of the compound was required to maintain the antitumor effect. The data presented here confirm that dacomitinib clearly affects receptor signaling in vivo and that its strong antitumoral effect is independent of the presence of mutant receptor isoforms although it could be affected by the PTEN status (as it is less effective in a PTEN-deleted GBM line). Dacomitinib is being tested in second line for EGFR-amplified GBMs. We hope that our results could help to select retrospectively molecular determinants of this response and to implement future trials with dacomitinib (alone or in combination with other inhibitors) in newly diagnosed GBMs.
Repisalud
Publication Artículo científico (JournalArticle)

DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis

  • Fernández-Martínez, P
  • Zahonero, Cristina
  • Sánchez-Gómez, Pilar
DYRK1A (dual-specificity tyrosine-regulated kinase 1A) is a kinase with multiple implications for embryonic development, especially in the nervous system where it regulates the balance between proliferation and differentiation of neural progenitors. The DYRK1A gene is located in the Down syndrome critical region and may play a significant role in the developmental brain defects, early neurodegeneration, and cancer susceptibility of individuals with this syndrome. DYRK1A is also expressed in adults, where it might participate in the regulation of cell cycle, survival, and tumorigenesis, thus representing a potential therapeutic target for certain types of cancer. However, the final readout of DYRK1A overexpression or inhibition depends strongly on the cellular context, as it has both tumor suppressor and oncogenic activities. Here, we will discuss the functions and substrates of DYRK1A associated with the control of cell growth and tumorigenesis with a focus on the potential use of DYRK1A inhibitors in cancer therapy.
Repisalud
Publication Artículo científico (JournalArticle)

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features

  • Manso, Rebeca
  • González-Rincón, Julia
  • Rodríguez-Justo, Manuel
  • Roncador, Giovanna
  • Gómez, Sagrario
  • Sánchez-Beato, Margarita
  • Piris, Miguel A
  • Rodríguez-Pinilla, Socorro M
The overlap of morphology and immunophenotype between angioimmunoblastic T-cell lymphoma (AITL) and other nodal peripheral T-cell lymphomas (n-PTCLs) is a matter of current interest whose clinical relevance and pathogenic background have not been fully established. We studied a series of 98 n-PTCL samples (comprising 57 AITL and 41 PTCL-NOS) with five TFH antibodies (CD10, BCL-6, PD-1, CXCL13, ICOS), looked for mutations in five of the genes most frequently mutated in AITL (TET2, DNMT3A, IDH2, RHOA and PLCG1) using the Next-Generation-Sequencing Ion Torrent platform, and measured the correlations of these characteristics with morphology and clinical features. The percentage of mutations in the RHOA and TET2 genes was similar (23.5% of cases). PLCG1 was mutated in 14.3%, IDH2 in 11.2% and DNMT3A in 7.1% of cases, respectively. In the complete series, mutations in RHOA gene were associated with the presence of mutations in IDH2, TET2 and DNMT3A (p < 0.001, p = 0.043, and p = 0.029, respectively). Fourteen cases featured RHOA mutations without TET2 mutations. A close relationship was found between the presence of these mutations and a TFH-phenotype in AITL and PTCL-NOS patients. Interestingly, BCL-6 expression was the only TFH marker differentially expressed between AITL and PTCL-NOS cases. There were many fewer mutated cases than there were cases with a TFH phenotype. Overall, these data suggest alternative ways by which neoplastic T-cells overexpress these proteins. On the other hand, no clinical or survival differences were found between any of the recognized subgroups of patients with respect to their immunohistochemistry or mutational profile.
Repisalud
Publication Artículo científico (JournalArticle)

Agreement among Mediterranean Diet Pattern Adherence Indexes: MCC-Spain Study

  • Olmedo-Requena, Rocío
  • González-Donquiles, Carmen
  • Dávila-Batista, Verónica
  • Romaguera, Dora
  • Castelló Pastor, Adela
  • Molina de la Torre, Antonio José
  • Amiano, Pilar
  • Dierssen-Sotos, Trinidad
  • Guevara, Marcela
  • Fernández-Tardón, Guillermo
  • Lozano-Lorca, Macarena
  • Alguacil, Juan
  • Peiró, Rosana
  • Huerta, José María
  • Gràcia-Lavedan, Esther
  • Aragones, Nuria
  • Fernández-Villa, Tania
  • Solans, Marta
  • Gómez-Acebo, Inés
  • Castaño-Vinyals, Gemma
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Martín, Vicente
There are many different methods used to measure the degree of adherence to a Mediterranean diet (MD), limiting comparison and interpretation of their results. The concordance between different methodologies has been questioned and their evaluation recommended. The aim of this study was to evaluate the agreement among five indexes that measure adherence to a Mediterranean dietary pattern. The study population included healthy adults selected in the Multi-Case Control Spain (MCC-Spain) study recruited in 12 provinces. A total of 3640 controls were matched to cases by age and sex. To reach the aim, the following scores of adherence to a Mediterranean dietary pattern were calculated: Mediterranean diet score (MDS), alternative Mediterranean diet (aMED), relative Mediterranean diet (rMED), dietary score (DS) and literature-based adherence score (LBAS). The relative frequency of subjects with a high level of adherence to a MD varied from 22% (aMED index) to 37.2% (DS index). Similarly, a high variability was observed for the prevalence of a low level of MD: from 24% (rMED) to 38.4% (aMED). The correlation among MDS, aMED and rMED indexes was moderate, except for MDS and aMED with a high coefficient of correlation 0.75 (95% CI 0.74⁻0.77). The Cohen's Kappa coefficient among indexes showed a moderate⁻fair concordance, except for MDS and aMED with a 0.56 (95% CI 0.55⁻0.59) and 0.67 (95% CI 0.66⁻0.68) using linear and quadratic weighting, respectively. The existing MD adherence indexes measured the same, although they were based on different constructing algorithms and varied in the food groups included, leading to a different classification of subjects. Therefore, concordance between these indexes was moderate or low.
Repisalud
Publication Artículo científico (JournalArticle)

Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media

  • García-Romero, Noemí
  • González-Tejedo, Carmen
  • Carrión-Navarro, Josefa
  • Esteban-Rubio, Susana
  • Rackov, Gorjana
  • Rodríguez-Fanjul, Vanessa
  • Oliver-De La Cruz, Jorge
  • Prat-Acín, Ricardo
  • Peris-Celda, María
  • Blesa, David
  • Ramírez-Jiménez, Laura
  • Sánchez-Gómez, Pilar
  • Perona, Rosario
  • Escobedo-Lucea, Carmen
  • Belda-Iniesta, Cristobal
  • Ayuso-Sacido, Angel
Human gliomas harbour cancer stem cells (CSCs) that evolve along the course of the disease, forming highly heterogeneous subpopulations within the tumour mass. These cells possess self-renewal properties and appear to contribute to tumour initiation, metastasis and resistance to therapy. CSC cultures isolated from surgical samples are considered the best preclinical in vitro model for primary human gliomas. However, it is not yet well characterized to which extent their biological and functional properties change during in vitro passaging in the serum-free culture conditions. Here, we demonstrate that our CSC-enriched cultures harboured from one to several CSC clones from the human glioma sample. When xenotransplanted into mouse brain, these cells generated tumours that reproduced at least three different dissemination patterns found in original tumours. Along the passages in culture, CSCs displayed increased expression of stem cell markers, different ratios of chromosomal instability events, and a varied response to drug treatment. Our findings highlight the need for better characterization of CSC-enriched cultures in the context of their evolution in vitro, in order to uncover their full potential as preclinical models in the studies aimed at identifying molecular biomarkers and developing new therapeutic approaches of human gliomas.
Repisalud
Publication Artículo científico (JournalArticle)

Applied mathematics and nonlinear sciences in the war on cancer

  • Pérez-García, Víctor M
  • Fitzpatrick, Susan
  • Pérez-Romasanta, Luis A
  • Pešić, Milica
  • Schucht, Philippe
  • Arana, Estanislao
  • Sánchez-Gómez, Pilar
Cancer is a major health problem in the industrialized world being the second leading cause of death in the USA and EU after heart disease. A huge quantity of resources is spent every year on cancer research, resulting in a small, yet sustained, reduction in cancer death rates (in the last ten years this was about 1 − 2% per year in the US) [1]. However, there is a widespread concern about the slow pace at which these discoveries in fundamental biology are translated into safe and effective clinical interventions. Statistics is already considered to be a basic ingredient of medical education and routinely used in research, specifically in clinical studies. This is so even when many physicians have a limited understanding of statistics and risk analysis [2]. However, the potential of other mathematical tools such as differential equations, advanced numerical methods, optimization, etc, have not been broadly incorporated into medical research on clinical care. This is so in spite of the fact that these methods are part of the standard toolbox of the applied mathematician that have proven useful in many other fields of science and engineering.
Repisalud
Publication Artículo científico (JournalArticle)

The CSN3 subunit of the COP9 signalosome interacts with the HD region of Sos1 regulating stability of this GEF protein

  • Zarich-Dimitrievich, Natasha
  • Anta, Begoña
  • Fernández-Medarde, Alberto
  • Ballester, Alicia
  • de Lucas, Maria Pilar
  • Camara, Ana Belen
  • Anta-Felez, Berta
  • Oliva-Martinez, Jose Luis
  • Rojas-Cabañeros, Jose Maria
  • Santos, Eugenio
Sos1 is an universal, widely expressed Ras guanine nucleotide-exchange factor (RasGEF) in eukaryotic cells. Its N-terminal HD motif is known to be involved in allosteric regulation of Sos1 GEF activity through intramolecular interaction with the neighboring PH domain. Here, we searched for other cellular proteins also able to interact productively with the Sos1 HD domain. Using a yeast two-hybrid system, we identified the interaction between the Sos1 HD region and CSN3, the third component of the COP9 signalosome, a conserved, multi-subunit protein complex that functions in the ubiquitin-proteasome pathway to control degradation of many cellular proteins. The interaction of CSN3 with the HD of Sos1 was confirmed in vitro by GST pull-down assays using truncated mutants and reproduced in vivo by co-immunoprecipitation with the endogenous, full-length cellular Sos1 protein. In vitro kinase assays showed that PKD, a COP9 signalosome-associated-kinase, is able to phosphorylate Sos1. The intracellular levels of Sos1 protein were clearly diminished following CSN3 or PKD knockdown. A sizable fraction of the endogenous Sos1 protein was found ubiquitinated in different mammalian cell types. A significant reduction of RasGTP formation upon growth factor stimulation was also observed in CSN3-silenced as compared with control cells. Our data suggest that the interaction of Sos1 with the COP9 signalosome and PKD plays a significant role in maintenance of cellular Sos1 protein stability and homeostasis under physiological conditions and raises the possibility of considering the CSN/PKD complex as a potential target for design of novel therapeutic drugs.
Repisalud
Publication Artículo científico (JournalArticle)

Regulation of CBP and Tip60 coordinates histone acetylation at local and global levels during Ras-induced transformation.

  • Sánchez-Molina, Sara
  • Estarás, Conchi
  • Oliva-Martinez, Jose Luis
  • Akizu, Naiara
  • Asensio-Juan, Elena
  • Rojas-Cabañeros, Jose Maria
  • Martínez-Balbás, Marian A
Cell transformation is clearly linked to epigenetic changes. However, the role of the histone-modifying enzymes in this process is still poorly understood. In this study, we investigated the contribution of the histone acetyltransferase (HAT) enzymes to Ras-mediated transformation. Our results demonstrated that lysine acetyltransferase 5, also known as Tip60, facilitates histone acetylation of bulk chromatin in Ras-transformed cells. As a consequence, global H4 acetylation (H4K8ac and H4K12ac) increases in Ras-transformed cells, rendering a more decompacted chromatin than in parental cells. Furthermore, low levels of CREB-binding protein (CBP) lead to hypoacetylation of retinoblastoma 1 (Rb1) and cyclin-dependent kinase inhibitor 1B (Cdkn1b or p27Kip1) tumour suppressor gene promoters to facilitate Ras-mediated transformation. In agreement with these data, overexpression of Cbp counteracts Ras transforming capability in a HAT-dependent manner. Altogether our results indicate that CBP and Tip60 coordinate histone acetylation at both local and global levels to facilitate Ras-induced transformation.
Repisalud
Publication Artículo científico (JournalArticle)

Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study)

  • Weitzer, Jakob
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Gómez-Acebo, Inés
  • Guevara, Marcela
  • Amiano, Pilar
  • Martín, Vicente
  • Molina-Barceló, Ana
  • Alguacil, Juan
  • Moreno, Victor
  • Suarez-Calleja, Claudia
  • Jimenez-Moleon, Jose J.
  • Marcos-Gragera, Rafael
  • Papantoniou, Kyriaki
  • Perez-Gomez, Beatriz
  • Llorca, Javier
  • Ascunce, Nieves
  • Gil, Leire
  • Gràcia-Lavedan, Esther
  • Casabonne, Delphine
  • Lope Carvajal, Virginia
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
Experimental evidence indicates that exercise performed at different times of the day may affect circadian rhythms and circadian disruption has been linked to breast and prostate cancer. We examined in a population-based case-control study (MCC-Spain) if the time-of-day when physical activity is done affects prostate and breast cancer risk. Lifetime recreational and household physical activity was assessed by in-person interviews. Information on time-of-day of activity (assessed approximately 3 years after the assessment of lifetime physical activity and confounders) was available for 781 breast cancer cases, 865 population female controls, 504 prostate cases and 645 population male controls from 10 Spanish regions, 2008-2013. We estimated odds ratios (ORs) and 95% confidence intervals (95% CI) for different activity timings compared to inactive subjects using unconditional logistic regression adjusting for confounders. Early morning (8-10 am) activity was associated with a protective effect compared to no physical activity for both breast (OR = 0.74, 95% CI = 0.48-1.15) and prostate cancer (OR = 0.73, 95% CI = 0.44-1.20); meta-OR for the two cancers combined 0.74 (95%CI = 0.53-1.02). There was no effect observed for breast or prostate cancer for late morning to afternoon activity while a protective effect was also observed for evening activity only for prostate cancer (OR = 0.75, 95% CI = 0.45-1.24). Protective effects of early morning activity were more pronounced for intermediate/evening chronotypes for both cancers. This is the first population-based investigation identifying a differential effect of timing of physical activity on cancer risk with more pronounced effects for morning hour activity. Our results, if confirmed, may improve current physical activity recommendations for cancer prevention.
Repisalud
Publication Artículo científico (JournalArticle)

Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

  • Merlo, Anna
  • Bernardo-Castineira, Cristobal
  • Sáenz-de-Santa-María, Inés
  • Pitiot, Ana S.
  • Balbin, Milagros
  • Astudillo, Aurora
  • Valdes, Nuria
  • Scola, Bartolome
  • Del Toro, Raquel
  • Mendez-Ferrer, Simon
  • Piruat, Jose I.
  • Suarez, Carlos
  • Chiara, Maria-Dolores
The hypoxia-inducible factor 1 alpha (HIF-1 alpha) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding the cancer metabolic adjustments because of their associations with deregulations of metabolic enzymes, such as succinate dehydrogenase (SDH), and the von Hippel Lindau (VHL) gene involved in HIF-1 alpha stabilization. However, the role of miR-210 in the pathogenesis of SDH-related tumors remains an unmet challenge. Herein is described an in vivo genetic analysis of the role of VHL, HIF1A and SDH on miR-210 by using knockout murine models, siRNA gene silencing, and analyses of human tumors. HIF-1 alpha knockout abolished hypoxia-induced miR-210 expression in vivo but did not alter its constitutive expression in paraganglia. Normoxic miR-210 levels substantially increased by complete, but not partial, VHL silencing in paraganglia of knockout VHL-mice and by over-expression of p76del-mutated pVHL. Similarly, VHLmutated PGLs, not those with decreased VHL-gene/mRNA dosage, over-expressed miR-210 and accumulate HIF-1 alpha in most tumor cells. Ablation of SDH activity in SDHD-null cell lines or reduction of the SDHD or SDHB protein levels elicited by siRNA-induced gene silencing did not induce miR-210 whereas the presence of SDH mutations in PGLs and tumor-derived cell lines was associated with mild increase of miR-210 and the presence of a heterogeneous, HIF-1 alpha-positive and HIF-1 alpha-negative, tumor cell population. Thus, activation of HIF-1 alpha is likely an early event in VHLdefective PGLs directly linked to VHL mutations, but it is a late event favored but not directly triggered by SDHx mutations. This combined analysis provides insights into the mechanisms of HIF-1 alpha/miR-210 regulation in normal and tumor tissues potentially useful for understanding the pathogenesis of cancer and other diseases sharing similar underpinnings.
Repisalud
Publication Artículo científico (JournalArticle)

Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • de Pedro, María
  • Perez-Gomez, Beatriz
  • Castaño-Vinyals, Gemma
  • Fernández-Villa, Tania
  • Palazuelos-Calderón, Camilo
  • Amiano, Pilar
  • Etxeberria, Jaione
  • Benavente, Yolanda
  • Fernández-Tardón, Guillermo
  • Salcedo-Bellido, Inmaculada
  • Capelo, Rocío
  • Peiró, Rosana
  • Marcos-Gragera, Rafael
  • Huerta, José María
  • Tardón, Adonina
  • Barricarte, Aurelio
  • Altzibar, Jone M
  • Alonso-Molero, Jéssica
  • Dávila-Batista, Verónica
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease history. METHODS: Four thousand sixtyparticipants were selected using a pseudorandom number list from Family Practice lists in 12 Spanish provinces. They completed a face-to-face computerized interview on their NSAID consumption, demographic characteristics, body mass index, alcohol and tobacco consumption and medical history. In addition, participants completed a self-administered food-frequency and alcohol consumption questionnaire. Factors associated with ever and current NSAID consumption were identified by logistic regression. RESULTS: Women consumed more non-aspirin NSAIDs (38.8% [36.7-41.0]) than men (22.3 [20.5-24.2]), but men consumed more aspirin (11.7% [10.3-13.2]) than women (5.2% [4.3-6.3]). Consumption of non-aspirin NSAIDs decrease with age from 44.2% (39.4-49.1) in younger than 45 to 21.1% (18.3-24.2) in older than 75, but the age-pattern for aspirin usage was the opposite. Aspirin was reported by about 11% patients, as being twice as used in men (11.7%) than in women (5.2%); its consumption increased with age from 1.7% (< 45 years old) to 12.4% (≥75 years old). Aspirin was strongly associated with the presence of cardiovascular risk factors or established cardiovascular disease, reaching odds ratios of 15.2 (7.4-31.2) in women with acute coronary syndrome, 13.3 (6.2-28.3) in women with strokes and 11.1 (7.8-15.9) in men with acute coronary syndrome. Participants with cardiovascular risk factors or diseases consumed as much non-aspirin NSAID as participants without such conditions. CONCLUSIONS: Non-aspirin NSAIDs were more consumed by women and aspirin by men. The age patterns of aspirin and non-aspirin NSAIDs were opposite: the higher the age, the lower the non-aspirin NSAIDs usage and the higher the aspirin consumption. People with cardiovascular risk factors or diseases consumed more aspirin, but they did not decrease their non-aspirin NSAIDs usage.
Repisalud
Publication Artículo científico (JournalArticle)

Study of breast cancer incidence in patients of lymphangioleiomyomatosis.

  • Nuñez, Olivier
  • Román, Antonio
  • Johnson, Simon R
  • Inoue, Yoshikazu
  • Hirose, Masaki
  • Casanova, Álvaro
  • de Garibay, Gorka Ruiz
  • Herranz, Carmen
  • Bueno-Moreno, Gema
  • Boni, Jacopo
  • Mateo, Francesca
  • Petit, Anna
  • Climent, Fina
  • Soler, Teresa
  • Vidal, August
  • Sánchez-Mut, José Vicente
  • Esteller, Manel
  • López, José Ignacio
  • García, Nadia
  • Gumà, Anna
  • Ortega, Raúl
  • Plà, María Jesús
  • Campos, Miriam
  • Ansótegui, Emilio
  • Molina-Molina, María
  • Valenzuela, Claudia
  • Ussetti, Piedad
  • Laporta, Rosalía
  • Ancochea, Julio
  • Xaubet, Antoni
  • Pujana, Miguel Angel
  • Pollan-Santamaria, Marina
Molecular evidence has linked the pathophysiology of lymphangioleiomyomatosis (LAM) to that of metastatic breast cancer. Following on this observation, we assessed the association between LAM and subsequent breast cancer. An epidemiological study was carried out using three LAM country cohorts, from Japan, Spain, and the United Kingdom. The number of incident breast cancer cases observed in these cohorts was compared with the number expected on the basis of the country-specific incidence rates for the period 2000-2014. Immunohistochemical studies and exome sequence analysis were performed in two and one tumors, respectively. All cohorts revealed breast cancer standardized incidence ratios (SIRs) ≥ 2.25. The combined analysis of all cases or restricted to pre-menopausal age groups revealed significantly higher incidence of breast cancer: SIR = 2.81, 95 % confidence interval (CI) = 1.32-5.57, P = 0.009; and SIR = 4.88, 95 % CI = 2.29-9.99, P = 0.0007, respectively. Immunohistochemical analyses showed positivity for known markers of lung metastatic potential. This study suggests the existence of increased breast cancer risk among LAM patients. Prospective studies may be warranted to corroborate this result, which may be particularly relevant for pre-menopausal women with LAM.
Repisalud
Publication Artículo científico (JournalArticle)

The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation

  • Villanueva, Andrea A
  • Sánchez-Gómez, Pilar
  • Muñoz-Palma, Ernesto
  • Puvogel, Sofía
  • Casas, Bárbara S
  • Arriagada, Cecilia
  • Peña-Villalobos, Isaac
  • Lois, Pablo
  • Ramírez Orellana, Manuel
  • Lubieniecki, Fabiana
  • Casco Claro, Fernando
  • Gallegos, Iván
  • Garcia-Castro, Javier
  • Torres, Vicente A
  • Palma, Verónica
Neuroblastoma is a highly metastatic tumor that emerges from neural crest cell progenitors. Focal Adhesion Kinase (FAK) is a regulator of cell migration that binds to the receptor Neogenin-1 and is upregulated in neuroblastoma. Here, we show that Netrin-1 ligand binding to Neogenin-1 leads to FAK autophosphorylation and integrin β1 activation in a FAK dependent manner, thus promoting neuroblastoma cell migration. Moreover, Neogenin-1, which was detected in all tumor stages and was required for neuroblastoma cell migration, was found in a complex with integrin β1, FAK, and Netrin-1. Importantly, Neogenin-1 promoted neuroblastoma metastases in an immunodeficient mouse model. Taken together, these data show that Neogenin-1 is a metastasis-promoting protein that associates with FAK, activates integrin β1 and promotes neuroblastoma cell migration.
Repisalud
Publication Artículo científico (JournalArticle)

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.

  • Earl, Julie
  • Galindo-Pumariño, Cristina
  • Encinas, Jessica
  • Barreto, Emma
  • Castillo, Maria E
  • Pachón, Vanessa
  • Ferreiro, Reyes
  • Rodríguez-Garrote, Mercedes
  • González-Martínez, Silvia
  • Ramon Y Cajal, Teresa
  • Diaz, Luis Robles
  • Chirivella-Gonzalez, Isabel
  • Rodriguez, Montse
  • de Castro, Eva Martínez
  • García-Seisdedos, David
  • Muñoz, Gloria
  • Rosa, Juan Manuel Rosa
  • Marquez, Mirari
  • Carrato, Alfredo
  • Malats, Nuria
The 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) is around 5% due to the fact that the majority of patients present with advanced disease that is treatment resistant. Familial pancreatic cancer (FPC) is a rare disorder that is defined as a family with at least two affected first degree relatives, with an estimated incidence of 4%-10%. The genetic basis is unknown in the majority of families although around 10%-13% of families carry germline mutations in known genes associated with hereditary cancer and pancreatitis syndromes. Panel sequencing was performed of 35 genes associated with hereditary cancer in 43 PDAC cases from families with an apparent hereditary pancreatic cancer syndrome. Pathogenic variants were identified in 19% (5/26) of PDAC cases from pure FPC families in the genes MLH1, CDKN2A, POLQ and FANCM. Low frequency potentially pathogenic VUS were also identified in 35% (9/26) of PDAC cases from FPC families in the genes FANCC, MLH1, PMS2, CFTR, APC and MUTYH. Furthermore, an important proportion of PDAC cases harboured more than one pathogenic, likely pathogenic or potentially pathogenic VUS, highlighting the multigene phenotype of FPC. The genetic basis of familial or hereditary pancreatic cancer can be explained in 21% of families by previously described hereditary cancer genes. Low frequency variants in other DNA repair genes are also present in 35% of families which may contribute to the risk of pancreatic cancer development. This study was funded by the Instituto de Salud Carlos III (Plan Estatal de I + D + i 2013-2016): ISCIII (PI09/02221, PI12/01635, PI15/02101 and PI18/1034) and co-financed by the European Development Regional Fund ''A way to achieve Europe'' (ERDF), the Biomedical Research Network in Cancer: CIBERONC (CB16/12/00446), Red Temática de investigación cooperativa en cáncer: RTICC (RD12/0036/0073) and La Asociación Española contra el Cáncer: AECC (Grupos Coordinados Estables 2016).
Repisalud
Publication Artículo científico (JournalArticle)

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Palazuelos, Camilo
  • Perez-Gomez, Beatriz
  • Lope Carvajal, Virginia
  • Tusquets, Ignasi
  • Alonso, María Henar
  • Moreno, Victor
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Barricarte, Aurelio
  • Tardón, Adonina
  • Camacho, Antonio
  • Peiró-Pérez, Rosana
  • Marcos-Gragera, Rafael
  • Muñoz, Montse
  • Michelena-Echeveste, Maria Jesus
  • Ortega Valin, Luis
  • Guevara, Marcela
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
INTRODUCTION: The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers. METHODS: In this case-control study, we report the antihypertensive drugs-breast cancer relationship in 1,736 breast cancer cases and 1,895 healthy controls; results are reported stratifying by the women's characteristics (i.e., menopausal status or body mass index category) tumor characteristics and length of use of antihypertensive drugs. RESULTS: The relationship among breast cancer and use of calcium channel blockers (CCB) for 5 or more years had odds ratio (OR) = 1.77 (95% CI, 0.99 to 3.17). Stratifying by BMI, the OR increased significantly in the group with BMI ≥ 25 (OR 2.54, 95% CI, 1.24 to 5.22). CCBs were even more strongly associated with more aggressive tumors, (OR for invasive tumors = 1.96, 95% CI = 1.09 to 3.53; OR for non ductal cancers = 3.97, 95% CI = 1.73 to 9.05; OR for Erbb2+ cancer = 2.97, 95% CI: 1.20 to 7.32). On the other hand, premenopausal women were the only group in which angiotensin II receptor blockers may be associated with breast cancer (OR = 4.27, 95% CI = 1.32 to 13.84) but this could not be identified with any type or stage. Use of angiotensin-converting-enzyme inhibitors, beta blockers and diuretics were not associated with risk. CONCLUSIONS: In this large population-based study we found that long term use of calcium channel blockers is associated with some subtypes of breast cancer (and with breast cancer in overweight women).
Repisalud
Publication Artículo científico (JournalArticle)

Mammographic density and breast cancer in women from high risk families

  • Ramón Y Cajal, Teresa
  • Chirivella, Isabel
  • Miranda, Josefa
  • Teule, Alexandre
  • Izquierdo, Angel
  • Balmaña, Judith
  • Sánchez-Heras, Ana Beatriz
  • Llort, Gemma
  • Fisas, David
  • Lope Carvajal, Virginia
  • Hernandez-Agudo, Elena
  • Juan-Fita, María José
  • Tena, Isabel
  • Robles, Luis
  • Guillén-Ponce, Carmen
  • Pérez-Segura, Pedro
  • Luque-Molina, Mari Sol
  • Hernando-Polo, Susana
  • Salinas, Mónica
  • Brunet, Joan
  • Salas-Trejo, Dolores
  • Barnadas, Agustí
  • Pollan-Santamaria, Marina
INTRODUCTION: Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype. METHODS: The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling Units. Participants' density was scored retrospectively from available mammograms by a single blinded radiologist using a 5-category scale (<10 %, 10-25 %, 25-50 %, 50-75 %, >75 %). In BC cases, we selected mammograms taken prior to diagnosis or from the contralateral breast, whereas, in non-cases, the last screening mammogram was evaluated. MD distribution in carriers and non-carriers was compared using ordinal logistic models, and the association between MD and BC in BRCA1/2 mutation carriers was studied using logistic regression. Huber-White robust estimators of variance were used to take into account correlations between family members. A similar multinomial model was used to explore this association by BC subtype. RESULTS: We identified and scored mammograms from 341 BRCA1, 350 BRCA2 mutation carriers and 229 non-carriers. Compared to non-carriers, MD was significantly lower among BRCA2 mutation carriers (odds ratio (OR) =0.71; P-value=0.04), but not among BRCA1 carriers (OR=0.84; P-value=0.33). MD was associated with subsequent development BC (OR per category of MD=1.45; 95 % confidence interval=1.18-1.78, P-value<0.001), with no significant differences between BRCA1 and BRCA2 mutation carriers (P-value=0.48). Finally, no statistically significant differences were observed in the association of MD with specific BC subtypes. CONCLUSIONS: Our study, the largest to date on this issue, confirms that MD is an independent risk factor for all BC subtypes in either BRCA1 and BRCA2 mutation carriers, and should be considered a phenotype risk marker in this context.
Repisalud
Publication Artículo científico (JournalArticle)

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

  • Lawrenson, Kate
  • Kar, Siddhartha
  • McCue, Karen
  • Kuchenbaeker, Karoline B
  • Michailidou, Kyriaki
  • Tyrer, Jonathan
  • Beesley, Jonathan
  • Ramus, Susan J
  • Li, Qiyuan
  • Delgado, Melissa K
  • Lee, Janet M
  • Aittomäki, Kristiina
  • Andrulis, Irene L
  • Anton-Culver, Hoda
  • Arndt, Volker
  • Arun, Banu K
  • Arver, Brita
  • Bandera, Elisa V
  • Barile, Monica
  • Barkardottir, Rosa B
  • Barrowdale, Daniel
  • Beckmann, Matthias W
  • Benitez, Javier
  • Berchuck, Andrew
  • Bisogna, Maria
  • Bjorge, Line
  • Blomqvist, Carl
  • Blot, William
  • Bogdanova, Natalia
  • Bojesen, Anders
  • Bojesen, Stig E
  • Bolla, Manjeet K
  • Bonanni, Bernardo
  • Børresen-Dale, Anne-Lise
  • Brauch, Hiltrud
  • Brennan, Paul
  • Brenner, Hermann
  • Bruinsma, Fiona
  • Brunet, Joan
  • Buhari, Shaik Ahmad
  • Burwinkel, Barbara
  • Butzow, Ralf
  • Buys, Saundra S
  • Cai, Qiuyin
  • Caldes, Trinidad
  • Campbell, Ian
  • Canniotto, Rikki
  • Chang-Claude, Jenny
  • Chiquette, Jocelyne
  • Choi, Ji-Yeob
  • Claes, Kathleen B M
  • Cook, Linda S
  • Cox, Angela
  • Cramer, Daniel W
  • Cross, Simon S
  • Cybulski, Cezary
  • Czene, Kamila
  • Daly, Mary B
  • Damiola, Francesca
  • Dansonka-Mieszkowska, Agnieszka
  • Darabi, Hatef
  • Dennis, Joe
  • Devilee, Peter
  • Diez, Orland
  • Doherty, Jennifer A
  • Domchek, Susan M
  • Dorfling, Cecilia M
  • Dörk, Thilo
  • Dumont, Martine
  • Ehrencrona, Hans
  • Ejlertsen, Bent
  • Ellis, Steve
  • Engel, Christoph
  • Lee, Eunjung
  • Evans, D Gareth
  • Fasching, Peter A
  • Feliubadalo, Lidia
  • Figueroa, Jonine
  • Flesch-Janys, Dieter
  • Fletcher, Olivia
  • Flyger, Henrik
  • Foretova, Lenka
  • Fostira, Florentia
  • Foulkes, William D
  • Fridley, Brooke L
  • Friedman, Eitan
  • Frost, Debra
  • Gambino, Gaetana
  • Ganz, Patricia A
  • Garber, Judy
  • García-Closas, Montserrat
  • Gentry-Maharaj, Aleksandra
  • Ghoussaini, Maya
  • Giles, Graham G
  • Glasspool, Rosalind
  • Godwin, Andrew K
  • Goldberg, Mark S
  • Goldgar, David E
  • González-Neira A, Anna
  • Goode, Ellen L
  • Goodman, Marc T
  • Greene, Mark H
  • Gronwald, Jacek
  • Guénel, Pascal
  • Haiman, Christopher A
  • Hall, Per
  • Hallberg, Emily
  • Hamann, Ute
  • Hansen, Thomas V O
  • Harrington, Patricia A
  • Hartman, Mikael
  • Hassan, Norhashimah
  • Healey, Sue
  • Heitz, Florian
  • Herzog, Josef
  • Høgdall, Estrid
  • Høgdall, Claus K
  • Hogervorst, Frans B L
  • Hollestelle, Antoinette
  • Hopper, John L
  • Hulick, Peter J
  • Huzarski, Tomasz
  • Imyanitov, Evgeny N
  • Isaacs, Claudine
  • Ito, Hidemi
  • Jakubowska, Anna
  • Janavicius, Ramunas
  • Jensen, Allan
  • John, Esther M
  • Johnson, Nichola
  • Kabisch, Maria
  • Kang, Daehee
  • Kapuscinski, Miroslav
  • Karlan, Beth Y
  • Khan, Sofia
  • Kiemeney, Lambertus A
  • Kjaer, Susanne Kruger
  • Knight, Julia A
  • Konstantopoulou, Irene
  • Kosma, Veli-Matti
  • Kristensen, Vessela
  • Kupryjanczyk, Jolanta
  • Kwong, Ava
  • de la Hoya, Miguel
  • Laitman, Yael
  • Lambrechts, Diether
  • Le, Nhu
  • De Leeneer, Kim
  • Lester, Jenny
  • Levine, Douglas A
  • Li, Jingmei
  • Lindblom, Annika
  • Long, Jirong
  • Lophatananon, Artitaya
  • Loud, Jennifer T
  • Lu, Karen
  • Lubinski, Jan
  • Mannermaa, Arto
  • Manoukian, Siranoush
  • Le Marchand, Loic
  • Margolin, Sara
  • Marme, Frederik
  • Massuger, Leon F A G
  • Matsuo, Keitaro
  • Mazoyer, Sylvie
  • McGuffog, Lesley
  • McLean, Catriona
  • McNeish, Iain
  • Meindl, Alfons
  • Menon, Usha
  • Mensenkamp, Arjen R
  • Milne, Roger L
  • Montagna, Marco
  • Moysich, Kirsten B
  • Muir, Kenneth
  • Mulligan, Anna Marie
  • Nathanson, Katherine L
  • Ness, Roberta B
  • Neuhausen, Susan L
  • Nevanlinna, Heli
  • Nord, Silje
  • Nussbaum, Robert L
  • Odunsi, Kunle
  • Offit, Kenneth
  • Olah, Edith
  • Olopade, Olufunmilayo I
  • Olson, Janet E
  • Olswold, Curtis
  • O'Malley, David
  • Orlow, Irene
  • Orr, Nick
  • Osorio, Ana
  • Park, Sue Kyung
  • Pearce, Celeste L
  • Pejovic, Tanja
  • Peterlongo, Paolo
  • Pfeiler, Georg
  • Phelan, Catherine M
  • Poole, Elizabeth M
  • Pylkäs, Katri
  • Radice, Paolo
  • Rantala, Johanna
  • Rashid, Muhammad Usman
  • Rennert, Gad
  • Rhenius, Valerie
  • Rhiem, Kerstin
  • Risch, Harvey A
  • Rodriguez, Gus
  • Rossing, Mary Anne
  • Rudolph, Anja
  • Salvesen, Helga B
  • Sangrajrang, Suleeporn
  • Sawyer, Elinor J
  • Schildkraut, Joellen M
  • Schmidt, Marjanka K
  • Schmutzler, Rita K
  • Sellers, Thomas A
  • Seynaeve, Caroline
  • Shah, Mitul
  • Shen, Chen-Yang
  • Shu, Xiao-Ou
  • Sieh, Weiva
  • Singer, Christian F
  • Sinilnikova, Olga M
  • Slager, Susan
  • Song, Honglin
  • Soucy, Penny
  • Southey, Melissa C
  • Stenmark-Askmalm, Marie
  • Stoppa-Lyonnet, Dominique
  • Sutter, Christian
  • Swerdlow, Anthony
  • Tchatchou, Sandrine
  • Teixeira, Manuel R
  • Teo, Soo H
  • Terry, Kathryn L
  • Terry, Mary Beth
  • Thomassen, Mads
  • Tibiletti, Maria Grazia
  • Tihomirova, Laima
  • Tognazzo, Silvia
  • Toland, Amanda Ewart
  • Tomlinson, Ian
  • Torres, Diana
  • Truong, Thérèse
  • Tseng, Chiu-Chen
  • Tung, Nadine
  • Tworoger, Shelley S
  • Vachon, Celine
  • van den Ouweland, Ans M W
  • van Doorn, Helena C
  • van Rensburg, Elizabeth J
  • Van't Veer, Laura J
  • Vanderstichele, Adriaan
  • Vergote, Ignace
  • Vijai, Joseph
  • Wang, Qin
  • Wang-Gohrke, Shan
  • Weitzel, Jeffrey N
  • Wentzensen, Nicolas
  • Whittemore, Alice S
  • Wildiers, Hans
  • Winqvist, Robert
  • Wu, Anna H
  • Yannoukakos, Drakoulis
  • Yoon, Sook-Yee
  • Yu, Jyh-Cherng
  • Zheng, Wei
  • Zheng, Ying
  • Khanna, Kum Kum
  • Simard, Jacques
  • Monteiro, Alvaro N
  • French, Juliet D
  • Couch, Fergus J
  • Freedman, Matthew L
  • Easton, Douglas F
  • Dunning, Alison M
  • Pharoah, Paul D
  • Edwards, Stacey L
  • Chenevix-Trench, Georgia
  • Antoniou, Antonis C
  • Gayther, Simon A
A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10(-20)), ER-negative BC (P=1.1 × 10(-13)), BRCA1-associated BC (P=7.7 × 10(-16)) and triple negative BC (P-diff=2 × 10(-5)). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10(-3)) and ABHD8 (P<2 × 10(-3)). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3'-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk.
Repisalud
Publication Artículo científico (JournalArticle)

Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study

  • Alonso-Molero, Jéssica
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Fernandez de Larrea-Baz, Nerea
  • Guevara, Marcela
  • Amiano, Pilar
  • Castaño-Vinyals, Gemma
  • Fernández-Villa, Tania
  • Moreno, Victor
  • Bayo, Juan
  • Molina-Barceló, Ana
  • Fernández-Ortíz, María
  • Suarez-Calleja, Claudia
  • Marcos-Gragera, Rafael
  • Castells, Xavier
  • Gil-Majuelo, Leire
  • Ardanaz, Eva
  • Perez-Gomez, Beatriz
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
Breast cancer is the most frequent cause of tumors and net survival is increasing. Achieving a higher survival probability reinforces the importance of studying health-related quality of life (HR-QoL). The main aim of this work is to test the relationship between different sociodemographic, clinical and tumor-intrinsic characteristics, and treatment received with HR-QoL measured using SF-12 and the FACT/NCCN (National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy) Breast Symptom Index (FBSI). Women with breast cancer recruited between 2008 and 2013 and followed-up until 2017-2018 in a prospective cohort answered two HR-QoL surveys: the SF-12 and FBSI. The scores obtained were related to woman and tumor characteristics using linear regression models. The telephone survey was answered by 1078 women out of 1685 with medical record follow-up (64%). Increases in all three HR-QoL scores were associated with higher educational level. The score differences between women with university qualifications and women with no schooling were 5.43 for PCS-12, 6.13 for MCS-12 and 4.29 for FBSI. Histological grade at diagnosis and recurrence in the follow-up displayed a significant association with mental and physical HR-QoL, respectively. First-line treatment received was not associated with HR-QoL scores. On the other hand, most tumor characteristics were not associated with HR-QoL. As breast cancer survival is improving, further studies are needed to ascertain if these differences still hold in the long run.
Repisalud
Publication Artículo científico (JournalArticle)

c-Jun N-terminal kinase phosphorylation is a biomarker of plitidepsin activity

  • Muñoz-Alonso, María J
  • Álvarez, Enrique
  • Guillén-Navarro, María José
  • Pollan-Santamaria, Marina
  • Avilés, Pablo
  • Galmarini, Carlos M
  • Muñoz, Alberto
Plitidepsin is an antitumor drug of marine origin currently in Phase III clinical trials in multiple myeloma. In cultured cells, plitidepsin induces cell cycle arrest or an acute apoptotic process in which sustained activation of c-Jun N-terminal kinase (JNK) plays a crucial role. With a view to optimizing clinical use of plitidepsin, we have therefore evaluated the possibility of using JNK activation as an in vivo biomarker of response. In this study, we show that administration of a single plitidepsin dose to mice xenografted with human cancer cells does indeed lead to increased phosphorylation of JNK in tumors at 4 to 12 h. By contrast, no changes were found in other in vitro plitidepsin targets such as the levels of phosphorylated-ERK, -p38MAPK or the protein p27KIP1. Interestingly, plitidepsin also increased JNK phosphorylation in spleens from xenografted mice showing similar kinetics to those seen in tumors, thereby suggesting that normal tissues might be useful for predicting drug activity. Furthermore, plitidepsin administration to rats at plasma concentrations comparable to those achievable in patients also increased JNK phosphorylation in peripheral mononuclear blood cells. These findings suggest that changes in JNK activity provide a reliable biomarker for plitidepsin activity and this could be useful for designing clinical trials and maximizing the efficacy of plitidepsin.
Repisalud
Publication Artículo científico (JournalArticle)

Flavonoids and the Risk of Gastric Cancer: An Exploratory Case-Control Study in the MCC-Spain Study

  • Vitelli-Storelli, Facundo
  • Molina, Antonio José
  • Zamora-Ros, Raúl
  • Fernández-Villa, Tania
  • Roussou, Vasiliki
  • Romaguera, Dora
  • Aragones, Nuria
  • Obón-Santacana, Mireia
  • Guevara, Marcela
  • Gómez-Acebo, Inés
  • Fernández-Tardón, Guillermo
  • Molina-Barceló, Ana
  • Olmedo-Requena, Rocío
  • Capelo, Rocío
  • Chirlaque, María-Dolores
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Castilla Catalán, Jesús
  • Rubín-García, María
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Lera, Juan Pablo Barrio
  • Martín, Vicente
Several epidemiological studies have investigated the association between the dietary flavonoid intake and gastric cancer (GC) risk; however, the results remain inconclusive. Investigating the relationship between the different classes of flavonoids and the histological types and origin of GC can be of interest to the research community. We used data from a population-based multi-case control study (MCC-Spain) obtained from 12 different regions of Spain. 2700 controls and 329 GC cases were included in this study. Odds ratios (ORs) were calculated using the mixed effects logistic regression considering quartiles of flavonoid intakes and log2. Flavonoid intake was associated with a lower GC risk (ORlog2 = 0.76; 95% CI = 0.65-0.89; ORq4vsq1 = 0.60; 95%CI = 0.40-0.89; ptrend = 0.007). Inverse and statistically significant associations were observed with anthocyanidins, chalcones, dihydroflavonols and flavan-3-ols. The isoflavanoid intake was positively associated with higher cancer risk, but without reaching a statistical significance. In general, no differences were observed in the GC risk according to the location and histological type. The flavonoid intake seems to be a protective factor against GC within the MCC-study. This effect may vary depending on the flavonoid class but not by the histological type and location of the tumor. Broader studies with larger sample size and greater geographical variability are necessary.
Repisalud
Publication Artículo científico (JournalArticle)

Validity of self-reported intensity of exposure to second-hand smoke at home against environmental and personal markers., Validación de la intensidad de la exposición pasiva al tabaco en el hogar reportada mediante cuestionario

  • Martínez-Sánchez, Jose M
  • González-Marrón, Adrián
  • Sureda, Xisca
  • Martín-Sánchez, Juan Carlos
  • Fu, Marcela
  • Pérez-Ortuño, Raúl
  • Lidón-Moyano, Cristina
  • Galan, Iñaki
  • Pascual, José Antonio
  • Fernández, Esteve
[EN] The objective of this study was to assess the validity of two questions about the perception of intensity of exposure to secondhand smoke (SHS) at home using as a reference environmental markers (airborne nicotine and benzene) and biomarkers of exposure (cotinine in saliva and urine). This was a cross-sectional study in a convenience sample of 49 non-smoking volunteers. We found a high correlation between selfreported SHS exposure and airborne nicotine (rsp = 0.806, p < 0.05), salivary cotinine (rsp = 0.752, p < 0.05), and urinary cotinine (rsp = 0.626, p < 0.05). We did not find differences between the score question and the conventional ones (p > 0.05). In conclusion, the significant correlation of the two questions proposed with environmental markers and personal markers indicates their potential validity to assess exposure to SHS at home. [ES] El objetivo de este trabajo es evaluar la validez de dos preguntas sobre la exposición al humo ambiental de tabaco (HAT) en el hogar utilizando como referencia marcadores ambientales (nicotina y bencenos en el aire) y biomarcadores específicos (cotinina en saliva y orina) de la exposición pasiva al tabaco. Para ello se realizó un estudio transversal de una muestra de conveniencia de 49 voluntarios no fumadores mayores de edad de la ciudad de Barcelona. Se encontró una alta correlación entre la pregunta de intensidad de la exposición pasiva autodeclarada en casa y la nicotina en el aire (rsp = 0,806, p < 0,05), la cotinina en saliva (rsp = 0,752, p < 0,05) y la cotinina en orina (rsp = 0,626, p < 0,05). No encontramos diferencias entre las preguntas puntuables y las convencionales (p >0,05). En conclusión, la alta correlación de las preguntas propuestas con los marcadores ambientales y los biomarcadores indica su validez para evaluar la intensidad de la exposición pasiva al tabaco en el hogar.
Repisalud
Publication Artículo científico (JournalArticle)

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

  • Lecarpentier, Julie
  • Silvestri, Valentina
  • Kuchenbaecker, Karoline B
  • Barrowdale, Daniel
  • Dennis, Joe
  • McGuffog, Lesley
  • Soucy, Penny
  • Leslie, Goska
  • Rizzolo, Piera
  • Navazio, Anna Sara
  • Valentini, Virginia
  • Zelli, Veronica
  • Lee, Andrew
  • Amin Al Olama, Ali
  • Tyrer, Jonathan P
  • Southey, Melissa
  • John, Esther M
  • Conner, Thomas A
  • Goldgar, David E
  • Buys, Saundra S
  • Janavicius, Ramunas
  • Steele, Linda
  • Ding, Yuan Chun
  • Neuhausen, Susan L
  • Hansen, Thomas V O
  • Osorio, Ana
  • Weitzel, Jeffrey N
  • Toss, Angela
  • Medici, Veronica
  • Cortesi, Laura
  • Zanna, Ines
  • Palli, Domenico
  • Radice, Paolo
  • Manoukian, Siranoush
  • Peissel, Bernard
  • Azzollini, Jacopo
  • Viel, Alessandra
  • Cini, Giulia
  • Damante, Giuseppe
  • Tommasi, Stefania
  • Peterlongo, Paolo
  • Fostira, Florentia
  • Hamann, Ute
  • Evans, D Gareth
  • Henderson, Alex
  • Brewer, Carole
  • Eccles, Diana
  • Cook, Jackie
  • Ong, Kai-Ren
  • Walker, Lisa
  • Side, Lucy E
  • Porteous, Mary E
  • Davidson, Rosemarie
  • Hodgson, Shirley
  • Frost, Debra
  • Adlard, Julian
  • Izatt, Louise
  • Eeles, Ros
  • Ellis, Steve
  • Tischkowitz, Marc
  • Godwin, Andrew K
  • Meindl, Alfons
  • Gehrig, Andrea
  • Dworniczak, Bernd
  • Sutter, Christian
  • Engel, Christoph
  • Niederacher, Dieter
  • Steinemann, Doris
  • Hahnen, Eric
  • Hauke, Jan
  • Rhiem, Kerstin
  • Kast, Karin
  • Arnold, Norbert
  • Ditsch, Nina
  • Wang-Gohrke, Shan
  • Wappenschmidt, Barbara
  • Wand, Dorothea
  • Lasset, Christine
  • Stoppa-Lyonnet, Dominique
  • Belotti, Muriel
  • Damiola, Francesca
  • Barjhoux, Laure
  • Mazoyer, Sylvie
  • Van Heetvelde, Mattias
  • Poppe, Bruce
  • De Leeneer, Kim
  • Claes, Kathleen B M
  • de la Hoya, Miguel
  • Garcia-Barberan, Vanesa
  • Caldes, Trinidad
  • Perez Segura, Pedro
  • Kiiski, Johanna I
  • Aittomäki, Kristiina
  • Khan, Sofia
  • Nevanlinna, Heli
  • van Asperen, Christi J
  • Vaszko, Tibor
  • Kasler, Miklos
  • Olah, Edith
  • Balmaña, Judith
  • Gutiérrez-Enríquez, Sara
  • Diez, Orland
  • Teulé, Alex
  • Izquierdo, Angel
  • Darder, Esther
  • Brunet, Joan
  • Del Valle, Jesús
  • Feliubadalo, Lidia
  • Pujana, Miquel Angel
  • Lazaro, Conxi
  • Arason, Adalgeir
  • Agnarsson, Bjarni A
  • Johannsson, Oskar Th
  • Barkardottir, Rosa B
  • Alducci, Elisa
  • Tognazzo, Silvia
  • Montagna, Marco
  • Teixeira, Manuel R
  • Pinto, Pedro
  • Spurdle, Amanda B
  • Holland, Helene
  • Lee, Jong Won
  • Lee, Min Hyuk
  • Lee, Jihyoun
  • Kim, Sung-Won
  • Kang, Eunyoung
  • Kim, Zisun
  • Sharma, Priyanka
  • Rebbeck, Timothy R
  • Vijai, Joseph
  • Robson, Mark
  • Lincoln, Anne
  • Musinsky, Jacob
  • Gaddam, Pragna
  • Tan, Yen Y
  • Berger, Andreas
  • Singer, Christian F
  • Loud, Jennifer T
  • Greene, Mark H
  • Mulligan, Anna Marie
  • Glendon, Gord
  • Andrulis, Irene L
  • Toland, Amanda Ewart
  • Senter, Leigha
  • Bojesen, Anders
  • Nielsen, Henriette Roed
  • Skytte, Anne-Bine
  • Sunde, Lone
  • Jensen, Uffe Birk
  • Pedersen, Inge Sokilde
  • Krogh, Lotte
  • Kruse, Torben A
  • Caligo, Maria A
  • Yoon, Sook-Yee
  • Teo, Soo-Hwang
  • von Wachenfeldt, Anna
  • Huo, Dezheng
  • Nielsen, Sarah M
  • Olopade, Olufunmilayo I
  • Nathanson, Katherine L
  • Domchek, Susan M
  • Lorenchick, Christa
  • Jankowitz, Rachel C
  • Campbell, Ian
  • James, Paul
  • Mitchell, Gillian
  • Orr, Nick
  • Park, Sue Kyung
  • Thomassen, Mads
  • Offit, Kenneth
  • Couch, Fergus J
  • Simard, Jacques
  • Easton, Douglas F
  • Chenevix-Trench, Georgia
  • Schmutzler, Rita K
  • Antoniou, Antonis C
  • Ottini, Laura
Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated-for the first time to our knowledge-associations of common genetic variants with breast and prostate cancer risks for male carriers of BRCA1/ 2 mutations and implications for cancer risk prediction. Materials and Methods We genotyped 1,802 male carriers of BRCA1/2 mutations from the Consortium of Investigators of Modifiers of BRCA1/2 by using the custom Illumina OncoArray. We investigated the combined effects of established breast and prostate cancer susceptibility variants on cancer risks for male carriers of BRCA1/2 mutations by constructing weighted polygenic risk scores (PRSs) using published effect estimates as weights. Results In male carriers of BRCA1/2 mutations, PRS that was based on 88 female breast cancer susceptibility variants was associated with breast cancer risk (odds ratio per standard deviation of PRS, 1.36; 95% CI, 1.19 to 1.56; P = 8.6 × 10-6). Similarly, PRS that was based on 103 prostate cancer susceptibility variants was associated with prostate cancer risk (odds ratio per SD of PRS, 1.56; 95% CI, 1.35 to 1.81; P = 3.2 × 10-9). Large differences in absolute cancer risks were observed at the extremes of the PRS distribution. For example, prostate cancer risk by age 80 years at the 5th and 95th percentiles of the PRS varies from 7% to 26% for carriers of BRCA1 mutations and from 19% to 61% for carriers of BRCA2 mutations, respectively. Conclusion PRSs may provide informative cancer risk stratification for male carriers of BRCA1/2 mutations that might enable these men and their physicians to make informed decisions on the type and timing of breast and prostate cancer risk management.
Repisalud
Publication Artículo científico (JournalArticle)

Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis

  • de Carcer Diez, Guillermo
  • Wachowicz, Paulina
  • Martinez-Martinez, Sara
  • Oller, Jorge
  • Mendez-Barbero, Nerea
  • Escobar, Beatriz
  • González-Loyola, Alejandra
  • Takaki, Tohru
  • El Bakkali, Aicha
  • Cámara, Juan A
  • Jimenez-Borreguero, Luis J.
  • Bustelo, Xosé R
  • Cañamero, Marta
  • Mulero, Francisca
  • de Los Ángeles Sevilla, María
  • Montero, María Jose
  • Redondo, Juan Miguel
  • Malumbres Martinez, Marcos
Polo-like kinase 1 (PLK1), an essential regulator of cell division, is currently undergoing clinical evaluation as a target for cancer therapy. We report an unexpected function of Plk1 in sustaining cardiovascular homeostasis. Plk1 haploinsufficiency in mice did not induce obvious cell proliferation defects but did result in arterial structural alterations, which frequently led to aortic rupture and death. Specific ablation of Plk1 in vascular smooth muscle cells (VSMCs) led to reduced arterial elasticity, hypotension, and an impaired arterial response to angiotensin II in vivo. Mechanistically, we found that Plk1 regulated angiotensin II-dependent activation of RhoA and actomyosin dynamics in VSMCs in a mitosis-independent manner. This regulation depended on Plk1 kinase activity, and the administration of small-molecule Plk1 inhibitors to angiotensin II-treated mice led to reduced arterial fitness and an elevated risk of aneurysm and aortic rupture. We thus conclude that a partial reduction of Plk1 activity that does not block cell division can nevertheless impair aortic homeostasis. Our findings have potentially important implications for current approaches aimed at PLK1 inhibition for cancer therapy.
Repisalud
Publication Artículo científico (JournalArticle)

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement

  • Quintanal-Villalonga, Alvaro
  • Carranza-Carranza, Andrés
  • Meléndez, Ricardo
  • Ferrer, Irene
  • Molina-Pinelo, Sonia
  • Paz Ares, Luis Gonzaga
BACKGROUND: The identification of prognostic biomarkers for lung squamous-cell carcinoma (SCC) pathology is crucial because of its poor prognosis. A variant of the FGFR4 (fibroblast growth factor receptor 4) gene, FGFR4-388Arg, has been associated with prognosis and is linked to oncogenesis in vitro in several types of cancer. We analyzed the association of this variant with prognosis and downstream signaling alteration in lung SCC patients. METHODS: The presence of the FGFR4-388Arg variant was determined in 114 formalin-fixed, paraffin-embedded lung SCC tissue samples by DNA genotyping and was correlated with clinicopathologic data. The activation of the protein kinase B (AKT) and mitogen-activated protein kinase (MAPK) pathways was determined by immunohistochemistry, and its association with the presence of FGFR4-388Arg was analyzed. RESULTS: We found that tumor differentiation status and adjuvant chemotherapy administration could be independent prognostic factors for overall survival (OS) in lymph node-affected patients, as expected. The progression-free survival and OS of patients with lymph node involvement (n = 41) and the FGFR4-388Arg genotype were significantly lower than those of patients lacking this variant (P = .035 and P = .042, respectively). Importantly, multivariate analysis supported the independent prognostic role of the FGFR4-388Arg genotype in OS (P = .025). Regarding downstream signaling, the FGFR4-388Arg genotype was not correlated with altered AKT signaling but was associated with increased MAPK activation in the SCC tumor samples (P = .017). CONCLUSION: The FGFR4-388Arg variant may represent a promising prognostic biomarker in SCC patients with lymph node involvement. For these patients, FGFR4 may be a potential therapeutic target.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Central tendency measure and wavelet transform combined in the non-invasive analysis of atrial fibrillation recordings

  • Alcaraz, Raúl
  • Rieta, J J|||0000-0002-3364-6380
Background Atrial fibrillation (AF) is the most common supraventricular arrhythmia in the clinical practice, being the subject of intensive research. Methods The present work introduces two different Wavelet Transform (WT) applications to electrocardiogram (ECG) recordings of patients in AF. The first one predicts spontaneous termination of paroxysmal AF (PAF), whereas the second one deals with the prediction of electrical cardioversion (ECV) outcome in persistent AF patients. In both cases, the central tendency measure (CTM) from the first differences scatter plot was applied to the AF wavelet decomposition. In this way, the wavelet coefficients vector CTM associated to the AF frequency scale was used to assess how atrial fibrillatory (f) waves variability can be related to AF events. Results Structural changes into the f waves can be assessed by combining WT and CTM to reflect atrial activity organization variation. This fact can be used to predict organization-related events in AF. To this respect, results in the prediction of PAF termination regarding sensitivity, specificity and accuracy were 100%, 91.67% and 96%, respectively. On the other hand, for ECV outcome prediction, 82.93% sensitivity, 90.91% specificity and 85.71% accuracy were obtained. Hence, CTM has reached the highest diagnostic ability as a single predictor published to date. Conclusions Results suggest that CTM can be considered as a promising tool to characterize non-invasive AF signals. In this sense, therapeutic interventions for the treatment of paroxysmal and persistent AF patients could be improved, thus, avoiding useless procedures and minimizing risks., This work was supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation and PPII11-0194-8121 and PII1C09-0036-3237 from Junta de Comunidades de Castilla-La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Bragg Gratings Inscribed in Solid-Core Microstructured Single-Mode Polymer Optical Fiber Drawn From a 3D-Printed Polycarbonate Preform

  • Zubel, Michal G.
  • Fasano, Andrea
  • Woyessa, Getinet Taffesse
  • Min, Rui
  • Leal-Junior, Arnaldo Gomes
  • Theodosiou, Antreas
  • Marques, Carlos A. F.
  • Rasmussen, Henrik K.
  • Bang, Ole
  • Kalli, Kyriacos
  • Frizera-Neto, Anselmo
  • Pontes, Maria Jose
  • Sugden, Kate
  • Ortega Tamarit, Beatriz|||0000-0003-1196-4756
[EN] This paper reports the first microstructured solid-core fiber drawn from a 3D-printed preform and the first fiber Bragg gratings inscribed in a fiber of this type. The presented fiber is made of polycarbonate and displays single-mode behavior. The fiber attenuation was the lowest reported so far for a POF drawn from a 3D-printed preform across a broad range of wavelengths. In addition, extensive fiber characterization results are presented and discussed including: fiber attenuation, mode simulations, dynamic thermomechanical analysis and thermo-optic coefficient. Fiber Bragg gratings are successfully inscribed in the produced fiber using three different lasers: a continuous wave helium-cadmium laser, a pulsed femtosecond frequency doubled ytterbium laser and ultra-violet nanosecond krypton fluoride laser. Mechanical testing of the fiber showed that the 3D printing approach did not introduce any unexpected or undesirable characteristics., This work was supported by the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2007-2013/, through Research Executive Agency (REA), under Grant 608382. The work of Carlos A. F. Marques was supported in part by the Fundacao para a Ciencia e a Tecnologia (FCT) under Grant UID/EEA/50008/2013, Grant UID/CTM/50025/2019, and Grant SAICTPAC/0036/2015, in part by the National Funds through the FCT/Ministerio da Educacao e Ciencia, in part by the European Regional Development Fund, through the PT2020 Partnership, and in part by national funds (OE), through FCT, in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of the article 23 (Decree-Law 57/2016, August 29, changed by Law 57/2017, July 19).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Assessment of non-invasive time and frequency atrial fibrillation organization markers with unipolar atrial electrograms

  • Alcaraz, Raúl
  • Hornero, Fernando
  • Rieta, J J|||0000-0002-3364-6380
The standard electrocardiogram (ECG) is the most common non-invasive way to study atrial fibrillation (AF). In this respect, previous works have shown that the surface lead V 1 reflects mainly the dominant atrial frequency (DAF) of the right atrium (RA), which has been widely used to study AF. In a similar way, AF organization and fibrillatory (f) wave amplitude are two recently proposed non-invasive AF markers. These markers need to be validated with invasive recordings in order to assess their capability to reliably reflect the internal fibrillatory activity dynamics. In this work, these two non-invasive metrics have been compared with similar measures recorded from two unipolar atrial electrograms (AEGs). For both ECG and AEG signals, AF organization has been computed by applying a nonlinear regularity index, such as sample entropy (SampEn), to the atrial activity (AA) and to its fundamental waveform, defined as the main atrial wave (MAW). The surface and epicardial f wave amplitude has been estimated through their mean power. Results obtained for 38 patients showed statistically significant correlations between the values measured from surface and invasive recordings, thus corroborating the usefulness of the aforesaid markers in the non-invasive study of AF. Precisely, for AF organization computed from the MAW, the correlation coefficients between surface and both AEGs were R = 0.926 (p < 0.001) and R = 0.932 (p < 0.001). For f wave amplitude, slightly lower significant relationships were noticed, the correlation coefficients being R = 0.765 (p < 0.001) and R = 0.842 (p < 0.001). These outcomes together with interesting linear relationships found among the parameters suggest that AF regularity estimated via SampEn and f wave amplitude can non-invasively characterize the epicardial activity related to AF. © 2011 Institute of Physics and Engineering in Medicine., This work was supported by projects TEC2007-64884 and TEC2010-20633 from the Spanish Ministry of Science and Innovation, PII2C09-0224-5983, PPII11-0194-8121 and PII1C09-0036-3237 from Junta de Comunidades de Castilla La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Observador de alta ganancia con zona muerta ajustable para estimar la saturación de agua líquida en pilas de combustible tipo PEM, High gain observer with dynamic deadzone to estimate liquid water saturation in PEM fuel cells

  • Cecilia, A.
  • Costa-Castelló, R.
[EN] In the area of PEM fuel cells, water management remains one of the most challenging issues affecting PEMFC efficiency and lifetime. Liquid water active control and supervision techniques are limited by the absence of online sensors that can estimate the liquid water saturation. For this reason, this work presents the design of a state observer to estimate the cathode catalyst layer's liquid water saturation of an open-cathode PEM fuel cell. The proposed observer is based on High-Gain techniques, and is modified with a dynamic dead-zone which reduces the observer's noise sensibility. The results have been validated through numerical simulation and experiments. It is shown that, in the absence of noise, the proposed observer presents a similar performance than its non dead-zone equivalent. Moreover, in the presence of noise, the dead-zone significantly reduces the estimation error induced by it., [ES] En el campo de las pilas de combustible PEM, la gestión de agua líquida es una de las problemáticas más importantes que afectan a la eficiencia y vida útil del sistema. Las técnicas de control activo y supervisión del agua se ven limitadas por la ausencia de sensores que puedan medir la saturación de agua líquida en línea. Por eso, en este trabajo se presenta el diseño de un observador de estado para la estimación de la saturación de agua líquida en la capa catalizadora del cátodo de una pila de combustible PEM de cátodo abierto. El observador propuesto se basa en técnicas de alta ganancia. Además, se modifica con una función de zona muerta autoajustable con el fin de reducir su sensibilidad al ruido en la medida. Los resultados se han validado mediante simulación numérica y experimentación. Estos muestran que, en ausencia de ruido, el observador propuesto presenta unas prestaciones similares a las de su equivalente sin zona muerta. Además, en presencia de ruido, la zona muerta disminuye significativamente el error de estimación inducido por este., Este proyecto se ha financiado parcialmente por el proyecto DOVELAR (ref. RTI2018-096001-B-C32). Este trabajo se ha realizado con el apoyo de la Agencia Estatal de Investigación española a través del sello de excelencia de María de Maeztu, IRI (MDM-2016-0656). Este trabajo se ha financiado parcialmente por AGAUR of Generalitat de Catalunya a través de la subvención del grupo Advanced Control Systems (SAC) (2017 SGR 482). Este trabajo se ha realizado con el apoyo de ACCIÓ (Operational Program FEDER Catalunya 2014-2020) a través de REFER project (COMRDI15-1-0036-11).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

miRNA detection methods and clinical implications in lung cancer

  • Usó, Marta
  • Bremnes, Roy M.
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Lung cancer is the leading cause of cancer death worldwide. Therefore, advances in the diagnosis and treatment of the disease are urgently needed. miRNAs are a family of small, noncoding RNAs that regulate gene expression at the transcriptional level. miRNAs have been reported to be deregulated and to play a critical role in different types of cancer, including lung cancer. Thus, miRNA profiling in lung cancer patients has become the core of several investigations. To this end, the development of a multitude of platforms for miRNA profiling analysis has been essential. This article focuses on the different technologies available for assessing miRNAs and the most important results obtained to date in lung cancer., This study was partially supported by a grant from the Ministerio de Ciencia e Inovacion de Espana (TRA09-0132), Beca Roche en Onco-Hematologia 2009 and Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Clinical information modeling processes for semantic interoperability of electronic health records: systematic review and inductive analysis

  • Moreno-Conde, Alberto
  • Moner Cano, David
  • Da Cruz, Wellington Dimas
  • Santos, Marcelo R.
  • Maldonado Segura, José Alberto
  • Robles Viejo, Montserrat
  • Kalra, Dipak
[EN] [Objective] This systematic review aims to identify and compare the existing processes and methodologies that have been published in the literature for defining clinical information models (CIMs) that support the semantic interoperability of electronic health record (EHR) systems. [Material and Methods] Following the preferred reporting items for systematic reviews and meta-analyses systematic review methodology, the authors reviewed published papers between 2000 and 2013 that covered that semantic interoperability of EHRs, found by searching the PubMed, IEEE Xplore, and ScienceDirect databases. Additionally, after selection of a final group of articles, an inductive content analysis was done to summarize the steps and methodologies followed in order to build CIMs described in those articles. [Results] Three hundred and seventy-eight articles were screened and thirty six were selected for full review. The articles selected for full review were analyzed to extract relevant information for the analysis and characterized according to the steps the authors had followed for clinical information modeling. [Discussion] Most of the reviewed papers lack a detailed description of the modeling methodologies used to create CIMs. A representative example is the lack of description related to the definition of terminology bindings and the publication of the generated models. However, this systematic review confirms that most clinical information modeling activities follow very similar steps for the definition of CIMs. Having a robust and shared methodology could improve their correctness, reliability, and quality. [Conclusion] Independently of implementation technologies and standards, it is possible to find common patterns in methods for developing CIMs, suggesting the viability of defining a unified good practice methodology to be used by any clinical information modeler., This research has been partially funded by the Instituto de Salud Carlos III (Platform for Innovation in Medical Technologies and Health), grant PT13/0006/0036 and the Spanish Ministry of Economy and Competitiveness, grants TIN2010-21388-C02-01 and PTQ-12-05620.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification

  • Juan Albarracín, Javier
  • Robles Viejo, Montserrat
  • Aparici, F.
  • Marti-Bonmati, L.
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
  • Garcia-Gomez, Juan M
Automatic brain tumour segmentation has become a key component for the future of brain tumour treatment. Currently, most of brain tumour segmentation approaches arise from the supervised learning standpoint, which requires a labelled training dataset from which to infer the models of the classes. The performance of these models is directly determined by the size and quality of the training corpus, whose retrieval becomes a tedious and time-consuming task. On the other hand, unsupervised approaches avoid these limitations but often do not reach comparable results than the supervised methods. In this sense, we propose an automated unsupervised method for brain tumour segmentation based on anatomical Magnetic Resonance (MR) images. Four unsupervised classification algorithms, grouped by their structured or non-structured condition, were evaluated within our pipeline. Considering the non-structured algorithms, we evaluated K-means, Fuzzy K-means and Gaussian Mixture Model (GMM), whereas as structured classification algorithms we evaluated Gaussian Hidden Markov Random Field (GHMRF). An automated postprocess based on a statistical approach supported by tissue probability maps is proposed to automatically identify the tumour classes after the segmentations. We evaluated our brain tumour segmentation method with the public BRAin Tumor Segmentation (BRATS) 2013 Test and Leaderboard datasets. Our approach based on the GMM model improves the results obtained by most of the supervised methods evaluated with the Leaderboard set and reaches the second position in the ranking. Our variant based on the GHMRF achieves the first position in the Test ranking of the unsupervised approaches and the seventh position in the general Test ranking, which confirms the method as a viable alternative for brain tumour segmentation., EFG was supported by Programa Torres Quevedo, Ministerio de Educacion y Ciencia, co-funded by the European Social Fund (PTQ-1205693). EFG, JMGG, and JVM were supported by Red Tematica de Investigacion Cooperativa en Cancer, (RTICC) 2013-2016 (RD12/0036/0020). JMGG was supported by Project TIN2013-43457-R: Caracterizacion de firmas biologicas de glioblastomas mediante modelos no-supervisados de prediccion estructurada basados en biomarcadores de imagen, co-funded by the Ministerio de Economia y Competitividad of Spain; CON2014001 UPV-IISLaFe: Unsupervised glioblastoma tumor components segmentation based on perfusion multiparametric MRI and spatio/temporal constraints; and CON2014002 UPV-IISLaFe: Empleo de segmentacion no supervisada multiparametrica basada en perfusion RM para la caracterizacion del edema peritumoral de gliomas y metastasis cerebrales unicas, funded by Instituto de Investigacion Sanitaria H. Universitario y Politecnico La Fe. This work was partially supported by the Instituto de Aplicaciones de las Tecnologias de la Informacion y las Comunicaciones Avanzadas (ITACA). Veratech for Health S.L. provided support in the form of salaries for author EF-G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The MATH-BTB BPM3 and BPM5 subunits of Cullin3-RING E3 ubiquitin ligases target PP2CA and other clade A PP2Cs for degradation

  • Julian-Valenzuela, Jose
  • Coego Gonzalez, Alberto
  • Lechner, Esther
  • Wu, Qian
  • Zhang, Xu
  • Merilo, Ebe
  • Park, Sang-Youl
  • Cutler, Sean R.
  • An, Chengcai
  • Genschik, Pascal
  • Lozano-Juste, Jorge|||0000-0001-7034-566X
  • Belda Palazón, Borja
  • Rodríguez Egea, Pedro Luís|||0000-0002-5886-9425
[EN] Early abscisic acid signaling involves degradation of clade A protein phosphatases type 2C (PP2Cs) as a complementary mechanism to PYR/PYL/RCAR-mediated inhibition of PP2C activity. At later steps, ABA induces up-regulation of PP2C transcripts and protein levels as a negative feedback mechanism. Therefore, resetting of ABA signaling also requires PP2C degradation to avoid excessive ABA-induced accumulation of PP2Cs. It has been demonstrated that ABA induces the degradation of existing ABI1 and PP2CA through the PUB12/13 and RGLG1/5 E3 ligases, respectively. However, other unidentified E3 ligases are predicted to regulate protein stability of clade A PP2Cs as well. In this work, we identified BTB/POZ AND MATH DOMAIN proteins (BPMs), substrate adaptors of the multimeric cullin3 (CUL3)-RING-based E3 ligases (CRL3s), as PP2CA-interacting proteins. BPM3 and BPM5 interact in the nucleus with PP2CA as well as with ABI1, ABI2, and HAB1. BPM3 and BPM5 accelerate the turnover of PP2Cs in an ABA-dependent manner and their overexpression leads to enhanced ABA sensitivity, whereas bpm3 bpm5 plants show increased accumulation of PP2CA, ABI1 and HAB1, which leads to global diminished ABA sensitivity. Using biochemical and genetic assays, we demonstrated that ubiquitination of PP2CA depends on BPM function. Given the formation of receptor-ABA-phosphatase ternary complexes is markedly affected by the abundance of protein components and ABA concentration, we reveal that BPMs and multimeric CRL3 E3 ligases are important modulators of PP2C coreceptor levels to regulate early ABA signaling as well as the later desensitizing-resetting steps., Work in P.L.R.'s laboratory was supported by the Ministerio de Ciencia, Innovacion y Universidades (MICIU), Fondo Europeo de Desarrollo Regional, and Consejo Superior de Investigaciones Cientificas (grants BIO2014-52537-R and BIO2017-82503-R). P.G. acknowledges support from the Agence Nationale de la Recherche Laboratoires d'Excellence (grant ANR-10-LABX-0036_NETRNA). B.B.-P. was funded by Programa VALi+d GVA APOSTD/2017/039. J.J. was supported by a Formacion de Personal Investigador contract from MICIU. J.L.-J. was supported by a Juan de la Cierva contract from MICIU and by the Marie Sklodowska-Curie Action (grant H2020-MSCA-IF-2015-707477). E.M. was supported by the Estonian Research Council (grant PUT1133). We acknowledge Dr. Pablo Tornero for the gift of the pDEST15 plasmid and anti-GST antibody.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer

  • Loras, Alba
  • Quintás, Guillermo
  • Gil Grau, Salvador
  • Ruiz-Cerdá, José Luis
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Patients with non-muscle invasive bladder cancer (NMIBC) undergo lifelong monitoring based on repeated cystoscopy and urinary cytology due to the high recurrence rate of this tumor. Nevertheless, these techniques have some drawbacks, namely, low accuracy in detection of low-grade tumors, omission of pre-neoplastic lesions and carcinomas in situ (CIS), invasiveness, and high costs. This work aims to identify a urinary metabolomic signature of recurrence by proton Nuclear Magnetic Resonance (H-1 NMR) spectroscopy for the follow-up of NMIBC patients. To do this, changes in the urinary metabolome before and after transurethral resection (TUR) of tumors are analyzed and a Partial Least Square Discriminant Analysis (PLS-DA) model is developed. The usefulness of this discriminant model for the detection of tumor recurrences is assessed using a cohort of patients undergoing monitoring. The trajectories of the metabolomic profile in the follow-up period provide a negative predictive value of 92.7% in the sample classification. Pathway analyses show taurine, alanine, aspartate, glutamate, and phenylalanine perturbed metabolism associated with NMIBC. These results highlight the potential of H-1 NMR metabolomics to detect bladder cancer (BC) recurrences through a non-invasive approach., This work was partly supported by the financial support of FEDER cofounded MINECO grant NANOPROBE, MAT2015-64139-C4-1-R, MAT2015-64139-C4-2-R, RTI2018-100910-B-C41 and RTI2018-100910-B-C43 (MCUI/AEI/FEDER, UE), ISCIII-RETICRD12/0036/0009, CTQ2016-79561-P, PROMETEO II/2014/047 and PROMETEO 2018/024. A.L. acknowledges a predoctoral grant from the Generalitat Valenciana (VALI+D ACIF/2015/115).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Background There is a medical need for diagnostic biomarkers in lung cancer. We evaluated the diagnostic performance of complement activation fragments. Methods We assessed complement activation in four bronchial epithelial and seven lung cancer cell lines. C4d, a degradation product of complement activation, was determined in 90 primary lung tumors; bronchoalveolar lavage supernatants from patients with lung cancer (n = 50) and nonmalignant respiratory diseases (n = 22); and plasma samples from advanced (n = 50) and early lung cancer patients (n = 84) subjects with inflammatory lung diseases (n = 133), and asymptomatic individuals enrolled in a lung cancer computed tomography screening program (n = 190). Two-sided P values were calculated by Mann-Whitney U test. Results Lung cancer cells activated the classical complement pathway mediated by C1q binding that was inhibited by phosphomonoesters. Survival was decreased in patients with high C4d deposition in tumors (hazard ratio [HR] = 3.06; 95% confidence interval [CI] = 1.18 to 7.91). C4d levels were increased in bronchoalveolar lavage fluid from lung cancer patients compared with patients with nonmalignant respiratory diseases (0.61 +/- 0.87 vs 0.16 +/- 0.11 mu g/mL; P < .001). C4d levels in plasma samples from lung cancer patients at both advanced and early stages were also increased compared with control subjects (4.13 +/- 2.02 vs 1.86 +/- 0.95 mu g/mL, P < 0.001; 3.18 +/- 3.20 vs 1.13 +/- 0.69 mu g/mL, P < .001, respectively). C4d plasma levels were associated with shorter survival in patients at advanced (HR = 1.59; 95% CI = 0.97 to 2.60) and early stages (HR = 5.57; 95% CI = 1.60 to 19.39). Plasma C4d levels were reduced after surgical removal of lung tumors (P < .001) and were associated with increased lung cancer risk in asymptomatic individuals with (n = 32) or without lung cancer (n = 158) (odds ratio = 4.38; 95% CI = 1.61 to 11.93). Conclusions Complement fragment C4d may serve as a biomarker for early diagnosis and prognosis of lung cancer., This work was supported by UTE project CIMA; the Spanish Government (grant numbers ISCIII-RTICC RD06/0020/0066, RD06/0020/1024, RD12/0036/0025, RD12/0036/0040, RD12/0036/0062, PI08/0923, PI10/01652, PI10/00166, and PI11/00618); the European Regional Development Fund; the European Community’s Seventh Framework Programme (HEALTH-F2-2010-258677- CURELUNG); and the Early Detection Research Network from the National Cancer Institute (grant number U01 CA152662). This work was supported (in part) by a grant (RD12/0036/XXXX) from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness & European Regional Development Fund “Una manera de hacer Europa”.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Classification of paroxysmal and persistent atrial fibrillation in ambulatory ECG recordings

  • Alcaraz, Raúl
  • Sandberg, Frida
  • Sornmo, Leif
  • Rieta, J J|||0000-0002-3364-6380
The problem of classifying short atrial fibrillatory segments in ambulatory ECG recordings as being either paroxysmal or persistent is addressed by investigating a robust approach to signal characterization. The method comprises preprocessing estimation of the dominant atrial frequency for the purpose of controlling the subbands of a filter bank, computation of the relative subband (harmonics) energy, and the subband sample entropy. Using minimum-error-rate classification of different feature vectors, a data set consisting of 24-h ambulatory recordings from 50 subjects with either paroxysmal (26) or persistent (24) atrial fibrillation (AF) was analyzed on a 10-s segment basis; a total of 212,196 segments were classified. The best performance in terms of area under the receiver operating characteristic curve was obtained for a feature vector defined by the subband sample entropy of the dominant atrial frequency and the relative harmonics energy, resulting in a value of 0.923, whereas that of the dominant atrial frequency was equal to 0.826. It is concluded that paroxysmal and persistent AFs can be discriminated from short segments with good accuracy at any time of an ambulatory recording. © 2006 IEEE., January 11, 2011; accepted January 22, 2011. Date of publication February 10, 2011; date of current version April 20, 2011. This work was supported in part by the Spanish Ministry of Science and Innovation under Project TEC2010-20633 and the Junta de Comunidades de Castilla La Mancha under Project PII2C09-0224-5983, Project PII1C09-0036-3237, and Project PPII11-0194-8121. Asterisk indicates corresponding author.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients

  • Usó, Marta
  • Calabuig-Farinas, Silvia
  • Blasco, Ana
  • Garcia del Olmo, Eva
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Tumors develop mechanisms to recruit tolerogenic immune cells and to induce the expression of molecules that act as immune checkpoints. This regulation of the immune microenvironment favors immune tolerance to the neoplastic cells. In this study, we have investigated the prognostic role of immune-checkpoint expression markers in a cohort of resectable non-small cell lung cancer (NSCLC) patients. RNA was isolated from fresh-frozen lung specimens (tumor and normal lung) (n = 178). RTqPCR was performed to analyze the relative expression of 20 immune-related genes that were normalized by the use of endogenous genes selected by GeNorm algorithm. Patients with higher expression levels of IL23A and LGALS2 presented better outcomes. In the clustering expression patterns, we observed that patients with higher expression of immunoregulatory genes had better survival rates. Additionally, these data were used to develop a gene expression score. Since CTLA4 and PD1 were associated with prognosis based on Cox regression analysis (Z-score > 1.5), a multivariate model including these two genes was created. Absolute regression coefficients from this analysis were used in order to calculate the immunecheckpoint score: (PD1 x 0.116) + (CTLA4 x 0.059) for each case. Kaplan-Meier survival analysis showed that patients with high immune-checkpoint score have longer overall survival (OS) [NR vs. 40.4 mo, p = 0.008] and longer relapse-free survival (RFS) [82.6 vs. 23 mo, p = 0.009]. Multivariate analysis in the entire cohort indicated that the immune-checkpoint score was an independent biomarker of prognosis for OS [HR: 0.308; 95% CI, 0.156-0.609; p = 0.001] and RFS [HR: 0.527; 95% CI, 0.298-0.933; p = 0.028] in early-stage NSCLC patients. In conclusion, this score provides relevant prognostic information for a better characterization of early stage NSCLS patients with strikingly different outcomes and who may be candidates for immune-based therapies., This work was supported by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025) and the Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

MicroRNAs: Promising New Antiangiogenic Targets in Cancer

  • Gallach, Sandra
  • Calabuig-Farinas, Silvia
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] MicroRNAs are one class of small, endogenous, non-coding RNAs that are approximately 22 nucleotides in length; they are very numerous, have been phylogenetically conserved, and involved in biological processes such as development, differentiation, cell proliferation, and apoptosis. MicroRNAs contribute to modulating the expression levels of specific proteins based on sequence complementarity with their target mRNA molecules and so they play a key role in both health and disease. Angiogenesis is the process of new blood vessel formation from preexisting ones, which is particularly relevant to cancer and its progression. Over the last few years, microRNAs have emerged as critical regulators of signalling pathways in multiple cell types including endothelial and perivascular cells. This review summarises the role of miRNAs in tumour angiogenesis and their potential implications as therapeutic targets in cancer., This study was partially supported by a Grant from Ministerio de Ciencia e Inovacion de Espana (TRA09-0132), Beca Roche en Onco-Hematologia 2009, and Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells

  • Soto-Cerrato, Vanessa
  • Manuel-Manresa, Pilar
  • Hernando, Elsa
  • Calabuig-Farinas, Silvia
  • Martinez-Romero, Alicia
  • Fernandez-Dueñas, Victor
  • Sahlholm, Kristoffer
  • Knoepfel, Thomas
  • Garcia-Valverde, Maria
  • Rodilla, Ananda M.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Farras, Rosa
  • Ciruela, Francisco
  • Perez-Tomas, Ricardo
  • Quesada, Roberto
Facilitated anion transport potentially represents a powerful tool to modulate various cellular functions. However, research into the biological effects of small molecule anionophores is still at an early stage. Here we have used two potent anionophore molecules inspired in the structure of marine metabolites tambjamines to gain insight into the effect induced by these compounds at the cellular level. We show how active anionophores, capable of facilitating the transmembrane transport of chloride and bicarbonate in model phospholipid liposomes, induce acidification of the cytosol and hyperpolarization of plasma cell membranes. We demonstrate how this combined effect can be used against cancer stem cells (CSCs). Hyperpolarization of cell membrane induces cell differentiation and loss of sternness of CSCs leading to effective elimination of this cancer cell subpopulation., This work was supported by grants from the Spanish government and the EU (FIS PI13/00089, PIS PI12/02838, FIS PI12/00956 and RD12/0036/0025), a grant from La Marato de TV3 Foundation (20132730), a grant from SEPAR (17/2014), Consejeria de Educacion de la Junta de Castilla y Leon (Project BU340U13), Ministerio de Economia y competitividad/Instituto de Salud Carlos III (SAF2014-55700-P), and ICREA Academia-2010. E.H. thanks the Junta de Castilla y Leon (Consejeria de Educacion) and the Fondo Social Europeo for a PIRTU contract. We thank Benjamin Torrejon and Esther Castano from CCiT (Centres Cientifics i Tecnologics, Campus de Bellvitge, Universitat de Barcelona), Sandra Tejedor (Centro de Investigacion Principe Felipe), Luis Korrodi-Gregorio (UB), and Andrea Sancho (UBU) for their technical support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Application of wavelet entropy to predict atrial fibrillation progression from the surface ECG

  • Alcaraz, Raúl
  • Rieta, J J|||0000-0002-3364-6380
Atrial fibrillation (AF) is the most common supraventricular arrhythmia in clinical practice, thus, being the subject of intensive research both in medicine and engineering. Wavelet Entropy (WE) is a measure of the disorder degree of a specific phenomena in both time and frequency domains, allowing to reveal underlying dynamical processes out of sight for other methods. The present work introduces two different WE applications to the electrocardiogram (ECG) of patients in AF. The first application predicts the spontaneous termination of paroxysmal AF (PAF), whereas the second one deals with the electrical cardioversion (ECV) outcome in persistent AF patients. In both applications, WE was used with the objective of assessing the atrial fibrillatory ( f ) waves organization. Structural changes into the f waves reflect the atrial activity organization variation, and this fact can be used to predict AF progression. To this respect, results in the prediction of PAF termination regarding sensitivity, specificity, and accuracy were 95.38%, 91.67%, and 93.60%, respectively. On the other hand, for ECV outcome prediction, 85.24% sensitivity, 81.82% specificity, and 84.05% accuracy were obtained. These results turn WE as the highest single predictor of spontaneous PAF termination and ECV outcome, thus being a promising tool to characterize non-invasive AF signals., This work was supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation and PPII11-0194-8121 and PII1C09-0036-3237 from Junta de Comunidades de Castilla-La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Application of artificial neural networks for versatile preprocessing of electrocardiogram recordings

  • Mateo, Jorge
  • Rieta, J J|||0000-0002-3364-6380
[EN] The electrocardiogram (ECG) is the most widely used method for diagnosis of heart diseases, where a good quality of recordings allows the proper interpretation and identification of physiological and pathological phenomena. However, ECG recordings often have interference from noises including thermal, muscle, baseline and powerline noises. These signals severely limit ECG recording utility and, hence, have to be removed. To deal with this problem, the present paper proposes an artificial neural network (ANN) as a filter to remove all kinds of noise in just one step. The method is based on a growing ANN which optimizes both the number of nodes in the hidden layer and the coefficient matrices, which are optimized by means of the Widrow-Hoff delta algorithm. The ANN has been trained with a database comprising all kinds of noise, both from synthesized and real ECG recordings, in order to handle any noise signal present in the ECG. The proposed system improves results yielded by conventional techniques of ECG filtering, such as FIR-based systems, adaptive filtering and wavelet filtering. Therefore, the algorithm could serve as an effective framework to substantially reduce noise in ECG recordings. In addition, the resulting ECG signal distortion is notably more reduced in comparison with conventional methodologies. In summary, the current contribution introduces a new method which is able to suppress all ECG interference signals in only one step with low ECG distortion and a high noise reduction., This work was partly sponsored by Universidad de Castilla-La Mancha, Patronato Universitario Cardenal Gil de Albornoz from Cuenca, the project TEC2010–20633 from the Spanish Ministry of Science and Innovation and PII2C09–0224–5983 and PII1C09–0036–3237 from Junta de Comunidades de Castilla La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer

  • Loras, Alba
  • Suárez-Cabrera, Cristian
  • Quintás, Guillermo
  • Paramio, Jesús M.
  • Gil Grau, Salvador
  • Ruiz-Cerdá, José Luis
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Metabolism reprogramming is considered a hallmark of cancer. The study of bladder cancer (BC) metabolism could be the key to developing new strategies for diagnosis and therapy. This work aimed to identify tissue and urinary metabolic signatures as biomarkers of BC and get further insight into BC tumor biology through the study of gene-metabolite networks and the integration of metabolomics and transcriptomics data. BC and control tissue samples (n = 44) from the same patients were analyzed by High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance and microarrays techniques. Besides, urinary profiling study (n = 35) was performed in the same patients to identify a metabolomic profile, linked with BC tissue hallmarks, as a potential non-invasive approach for BC diagnosis. The metabolic profile allowed for the classification of BC tissue samples with a sensitivity and specificity of 100%. The most discriminant metabolites for BC tissue samples reflected alterations in amino acids, glutathione, and taurine metabolic pathways. Transcriptomic data supported metabolomic results and revealed a predominant downregulation of metabolic genes belonging to phosphorylative oxidation, tricarboxylic acid cycle, and amino acid metabolism. The urinary profiling study showed a relation with taurine and other amino acids perturbed pathways observed in BC tissue samples, and classified BC from non-tumor urine samples with good sensitivities (91%) and specificities (77%). This urinary profile could be used as a non-invasive tool for BC diagnosis and follow-up., This research was funded by FEDER cofounded MINECO grant SAF2015-66015-R, MAT2015-64139-C4-1-R, MAT2015-64139-C4-3-R, ISCIII-RETICRD12/0036/0009, PIE 15/00076, CB/16/00228, CTQ2016-79561-P; and the PROMETEO II/2014/047 and PROMETEO 2018/24 projects.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Application of Artificial Neural Network for Reducing Random Coincidences in PET

  • Oliver, J,F.
  • Cabello, J.
  • Tortajada Velert, Salvador
  • Rafecas Lopez, Maria Magdalena
  • Fuster García, Elíes|||0000-0002-0716-8960
Positron Emission Tomography (PET) is based on the detection in coincidence of the two photons created in a positron annihilation. In conventional PET, this coincidence identification is usually carried out through a coincidence electronic unit. An accidental coincidence occurs when two photons arising from different annihilations are classified as a coincidence. Accidental coincidences are one of the main sources of image degradation in PET. Some novel systems allow coincidences to be selected post-acquisition in software, or in real time through a digital coincidence engine in an FPGA. These approaches provide the user with extra flexibility in the sorting process and allow the application of alternative coincidence sorting procedures. In this work a novel sorting procedure based on Artificial Neural Network (ANN) techniques has been developed. It has been compared to a conventional coincidence sorting algorithm based on a time coincidence window. The data have been obtained from Monte-Carlo simulations. A small animal PET scanner has been implemented to this end. The efficiency (the ratio of correct identifications) can be selected for both methods. In one case by changing the actual value of the coincidence window used, and in the other by changing a threshold at the output of the neural network. At matched efficiencies, the ANN-based method always produces a sorted output with a smaller random fraction. In addition, two differential trends are found: the conventional method presents a maximum achievable efficiency, while the ANN-based method is able to increase the efficiency up to unity, the ideal value, at the cost of increasing the random fraction. Images reconstructed using ANN sorted data (no compensation for randoms) present better contrast, and those image features which are more affected by randoms are enhanced. For the image quality phantom used in the paper, the ANN method decreases the spillover ratio by a factor of 18%., This work was supported by RD12/0036/0020 Red Tematica de Investigacion Coperativa en Cancer (RTICC) 2012; Ministerio de Ciencia e Innovacion through a JAE-Doc contract associated to CSIC and FSE co-financed; also under projects TEC-2007-61047 and FPA-2010-14891.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Capítulo o parte de un libro (BookPart)

X-ray diagnostics of dodecane jet in spray A conditions using the new one shot engine (NOSE)

  • Chiboud, Ibrahim
  • Arjouche, Hugo
  • Nilaphai, Ob
  • Dozias, Sebastian
  • Moreau, Bruno
  • Hespel, Camille
  • Foucher, Fabrice
  • Mounaïm-Rousselle, Christine
  • Pouvelse, Jean-Michel
  • Robert, Eric
[EN] Quantifying liquid mass distribution data in the dense near nozzle area to develop and optimize diesel spray by optical diagnostic is challenging. Optical methods, while providing valuable information, have intrinsic limitations due to the strong scattering of visible light at gas-liquid boundaries. Because of the high density of the droplets near the nozzle, most optical methods are ineffective in this area and prevent the acquisition of reliable quantitative data. X-ray diagnostics offer a solution to this issue, since the main interaction between the fuel and the X-rays is absorption, rather than scattering, thus X-ray technique offers an appealing alternative to optical techniques for studying fuel sprays. Over the last decade, x-ray radiography experiments have demonstrated the ability to perform quantitative measurements in complex sprays. In the present work, an X-ray technique based on X-ray absorption has been conducted to perform measurements in dodecane fuel spray injected from a single-hole nozzle at high injection pressure and high temperature. The working fluid has been doped with DPX 9 containing a Cerium additive, which acts as a contrast agent. The first step of this work was to address the effect of this dopant, which increases the sensitivity of X-ray diagnostics due its strong photon absorption, on the behavior and the physical characteristics of n-dodecane spray. Comparisons of the diffused back illumination images acquired from ndodecane spray with and without DPX 9 under similar operating conditions show several significant differences. The current data show clearly that the liquid penetration length is different when DPX 9 is mixed with dodecane. To address this problem, the dodecane was doped with a several quantities of DPX containing 25% ± 0.5 of Cerium. Experiments show that 1.25% of Ce doesn’t affect the behaviour of spray. Radiography and density measurements at ambient pressure and 60 bars are presented. Spray cone angle around 5° is obtained. The obtained data shows that the result is a compromise between the concentration of dopant for which the physical characteristics of the spray do not change and the visualization of the jet by X-ray for this concentration., This work is supported by ANR Research National Agency (ECN-France project). I.C. is supported by ANR PLANEX ANR-11-EQPX-0036-01.The authors would like to thank Thierry Seguelong for DPX9 supply and Gilles Bruneaux for scientific discussions.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Short-time regularity assessment of fibrillatory waves from the surface ECG in atrial fibrillation

  • Alcaraz, Raul
  • Hornero, Fernando
  • Martinez, Arturo
  • Rieta, J J|||0000-0002-3364-6380
This paper proposes the first non-invasive method for direct and short-time regularity quantification of atrial fibrillatory (f) waves from the surface ECG in atrial fibrillation (AF). Regularity is estimated by computing individual morphological variations among f waves, which are delineated and extracted from the atrial activity (AA) signal, making use of an adaptive signed correlation index. The algorithm was tested on real AF surface recordings in order to discriminate atrial signals with different organization degrees, providing a notably higher global accuracy (90.3%) than the two non-invasive AF organization estimates defined to date: the dominant atrial frequency (70.5%) and sample entropy (76.1%). Furthermore, due to its ability to assess AA regularity wave to wave, the proposed method is also able to pursue AF organization time course more precisely than the aforementioned indices. As a consequence, this work opens a new perspective in the non-invasive analysis of AF, such as the individualized study of each f wave, that could improve the understanding of AF mechanisms and become useful for its clinical treatment., The authors are grateful to Drs Javier Vinas, Elio Martin and Alejandro Vazquez for their contribution to classify blindly the AF episodes used in this work. This work was supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation and PPII11-0194-8121 and PII1C09-0036-3237 from Junta de Comunidades de Castilla-La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Noninvasive predictors of atrial fibrillation early recurrence after electrical cardioversion and their link to atrial remodeling

  • Alcaraz, Raúl
  • Hornero Sos, Fernando
  • Rieta, J J
[EN] Several clinical factors have been studied to predict atrial fibrillation (AF) recurrence after electrical cardioversion (ECV) with limited predictive value. In this work, several time-frequency parameters from the fibrillatory (f) waves characterization were studied to improve ECV outcome prediction at mid follow-up. By analyzing ECV outcome one month after the procedure of 63 persistent AF patients, f waves power (fWP) presented the highest predictive accuracy of 82.5%, whereas f waves organization, computed by sample entropy (SampEn), provided a 79.4%. Other analyzed features revealed accuracies lower than 70%. A stepwise discriminant analysis provided a model based on fWP and SampEn with 90.5% of accuracy. Moreover, a thorough analysis of the results allowed the outline of possible associations between these two features and the concomitant status of atrial remodeling. As a consequence, the information provided by advanced signal processing methodologies could be more effective in the prediction of long-standing AF early recurrences than previously analyzed clinical parameters., This work was supported by the projects TEC2010–20633 from the Spanish Ministry of Science and Innovation, and PII11–0194–8121 and PII1C09–0036–3237 from Junta de Comunidades de Castilla La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A guide to avoid method bias of chromium(III, VI) chemiluminescence determination by luminol-hydrogen peroxide reaction. Application to unknown water samples

  • Meseguer-Lloret, S.|||0000-0001-5726-032X
  • Tortajada-Genaro, Luis Antonio|||0000-0003-4021-5607
  • Campins-Falcó, P.
  • Blasco-Gómez, F.
[EN] Cr(III) and/or Cr(VI) determinations based on light emission produced by luminol oxidation by hydrogen peroxide in basic aqueous solution catalyzed by Cr(III) were studied in order to diagnose and/or avoid method bias. The calibration step was optimized, and the usefulness of the method for speciating chromium was tested. The use of the standard addition method in the linear interval concentration range made it possible to diagnose the accuracy of the method for real samples. Good results were obtained for several real water samples containing chromium at different concentrations. The proposed protocol made the method traceable with an appropriate certified reference material and with the reference method., The authors are grateful to the DGICYT (Project n PB 97-1387) and to the Generalitat Valenciana (GR-0036) for financial support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Ventricular activity morphological characterization: Ectopic beats removal in long term atrial fibrillation recordings

  • Martínez, A.
  • Alcaraz, R.
  • Rieta, J J|||0000-0002-3364-6380
Ectopic beats are early heart beats remarkably different to the normal beat morphology that provoke serious disturbances in electrocardiographic analysis. These beats are very common in atrial fibrillation (AF), causing important residua when ventricular activity has to be removed for atrial activity (AA) analysis. In this work, a method is proposed to cancel out ectopics by discriminating between normal and abnormal beats, with an accuracy higher than 99%, through QRS morphological delineation and characterization. The most similar ectopics to the one under cancellation are clustered to provide a very precise cancellation template. Simulated and real AF recordings were used to validate the method. A new index, able to estimate the presence of ventricular residue after ectopics cancellation, was defined. Results by using the 2, 4, 6, , 30 most similar ectopics to the one under study yielded optimal cancellation for templates composed of 10 beats. Furthermore, these beats were very likely located close to the ectopic under cancellation, which could facilitate the algorithm implementation. As conclusion, the proposed method is an effective way to remove ectopics from long term AF recordings and get them ready for the application of any QRST cancellation technique able to extract the AA in optimal conditions. Moreover, it could also detect, characterize and remove ectopics in any other type of non-AF recordings., This work was supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation and PPII11-0194-8121 and PII1C09-0036-3237 from Junta de Comunidades de Castilla La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value

  • Gallach-Garcia, Sandra
  • Calabuig-Fariñas, Silvia
  • Montaner, David
  • Alonso, Sergio
  • Blasco, Ana
  • Usó-Marco, Marta
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps-Herrero, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Background: The average five-year survival for non-small cell lung cancer (NSCLC) patients is approximately 15%. Emerging evidence indicates that microRNAs (miRNAs) constitute a new class of gene regulators in humans that may play an important role in tumorigenesis. Hence, there is growing interest in studying their role as possible new biomarkers whose expression is aberrant in cancer. Therefore, in this study we identified dysregulated miRNAs by next generation sequencing (NGS) and analyzed their prognostic value. Methods: Sequencing by oligo ligation detection technology was used to identify dysregulated miRNAs in a training cohort comprising paired tumor/normal tissue samples (N = 32). We validated 22 randomly selected differentially-expressed miRNAs by quantitative real time PCR in tumor and adjacent normal tissue samples (N = 178). Kaplan-Meier survival analysis and Cox regression were used in multivariate analysis to identify independent prognostic biomarkers. Results: NGS analysis revealed that 39 miRNAs were dysregulated in NSCLC: 28 were upregulated and 11 were downregulated. Twenty-two miRNAs were validated in an independent cohort. Interestingly, the group of patients with high expression of both miRNAs (miR-21(high) and miR-188(high)) showed shorter relapse-free survival (RFS) and overall survival (OS) times. Multivariate analysis confirmed that this combined signature is an independent prognostic marker for RFS and OS (p = 0.001 and p < 0.0001, respectively). Conclusions: NGS technology can specifically identify dysregulated miRNA profiles in resectable NSCLC samples. MiR-21 or miR-188 overexpression correlated with a negative prognosis, and their combined signature may represent a new independent prognostic biomarker for RFS and OS., This work was supported by the RD12/0036/0025 and RD06/0020/1024 PI12-02838, ISCIII, grants from the Fondo Europeo de Desarrollo Regional (FEDER), by funds from the Proyecto de Investigacion Fundamental Orientada a la Transmision de Conocimiento a la Empresa (TRACE; TRA09-0132) and Beca Roche Oncohematologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Interlanguage or Technology when Using English as Vehicular Language: what influences students productions online?

  • Torrado-Cespón, Milagros
[EN] This article seeks to explore what influences the production of accurate online written texts in English by speakers of Spanish. In order to do so, the cases where the pronoun “I” is not capitalized have been examined in detail to determine whether we are facing an error due to a lack of proficiency or whether the use of ICT is to blame. After going through the cases of “i” and observing the other mistakes made in the texts where they appear, ICT together with lack of proofreading, and interlanguage seem to be the possible answers. Although we can establish the use of technology and, therefore, Computer-Mediated Communication (CMC) as the cause of most cases in analogy with what happens with native speakers, further investigation is needed and new research with similar control groups where explicit corrective feedback is given could give us more clues about the behaviour of the participants., This work has been carried out in the frame of the emerging research project “Detección y análisis del comportamiento lingüístico de producciones escritas de estudiantes universitarios” (Project reference: B0036-1617-104-ETEL. Universidad Internacional de La Rioja, 2016-2018).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Radial basis function neural networks applied to efficient QRST cancellation in atrial fibrillation

  • Mateo, Jorge
  • Rieta, J J|||0000-0002-3364-6380
The most extended noninvasive technique for medical diagnosis and analysis of atrial fibrillation (AF) relies on the surface elctrocardiogram (ECG). In order to take optimal profit of the ECG in the study of AF, it is mandatory to separate the atrial activity (AA) from other cardioelectric signals. Traditionally, template matching and subtraction (TMS) has been the most widely used technique for single-lead ECGs, whereas multi-lead ECGs have been addressed through statistical signal processing techniques, like independent component analysis. In this contribution, a new QRST cancellation method based on a radial basis function (RBF) neural network is proposed. The system is able to provide efficient QRST cancellation and can be applied both to single and multi-lead ECG recordings. The learning algorithm used for training the RBF makes use of a special class of network, known as cosine RBF, by updating selected adjustable parameters to minimize the class-conditional variances at the outputs of the network. The experiments verify that RBFs trained by the proposed learning algorithm are capable of reducing the QRST complex dramatically, a property that is not shared by other methods and conventional feed-forward neural networks. Average Results (mean +/- std) for the RBF method in cross-correlation (CC) between original and estimated AA are CC = 0.95 +/- 0.038 being the mean square error (MSE) for the same signals, MSE = 0.311 +/- 0.078. Regarding spectral parameters, the dominant amplitude (DA) and the mean power spectral (MP) were DA = 1.15 +/- 0.18 and MP = 0.31 +/- 0.07, respectively. In contrast, traditional TMS-based methods yielded, for the best case, CC = 0.864 +/- 0.041, MSE = 0.577 +/- 0.097, DA = 0.84 +/- 0.25 and MP = 0.24 +/- 0.07. The results prove that the RBF based method is able to obtain a remarkable reduction of ventricular activity and a very accurate preservation of the AA, thus providing high quality dissociation between atrial and ventricular activities in AF recordings. (C) 2012 Elsevier Ltd. All rights reserved., This work has been supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation, PII1C09-0036-3237 and PII2C09-0224-5983 from Junta de Comunidades de Castilla la Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers

  • Usó-Marco, Marta
  • Bremnes, Roy M.
  • Calabuig-Fariñas, Silvia
  • Blasco-Cordellat, Ana
  • Pastor, Enrique
  • Borreda, Irene
  • Molina-Pinelo, Sonia
  • Paz-Ares, Luis
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Forteza, Jerónimo
  • Camps-Herrero, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] The prognosis of non-small cell lung cancer (NSCLC) remains poor and heterogeneous and new biomarkers are needed. As the immune system plays a pivotal role in cancer, the study of immune-related markers may provide valuable prognostic information of NSCLC. In 122 formalin-fixed, paraffin-embedded tumor tissue samples from early-stage NSCLC, tumor and tumor-near stromal areas were microdissected and gene expression levels of conventional and regulatory T cell markers were assessed by quantitative polymerase chain reaction. Also, the presence of infiltrating CD4+, CD8+, and FOXP3+ cells in tumor samples was assessed by immunohistochemistry. The relative proportion of conventional and regulatory T cells present in the tumor environment was assessed and found to be key to understand the importance that the immune system analysis has in the prognostics of NSCLC patients. The presence of CD8+ cells in the tumor compartment was associated with better outcome, whereas the presence of FOXP3+ cells was associated with worse overall survival. The negative prognostic value of combined biomarkers, indicating high levels of FOXP3 in the stroma and low levels of CD4 or CD8 in tumors, was observed at mRNA level and was validated by immunohistochemistry. In conclusion, the proportion of T helper and cytotoxic cells vs. regulatory T cells in different locations of the tumor microenvironment have opposite prognostic impacts in resected NSCLC., This work was supported by the Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0025) and the Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Study on the P-wave feature time course as early predictors of paroxysmal atrial fibrillation

  • Martinez, Arturo
  • Alcaraz, Raul
  • Rieta, J J|||0000-0002-3364-6380
Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, increasing the risk of stroke and all-cause mortality. Its mechanisms are poorly understood, thus leading to different theories and controversial interpretation of its behavior. In this respect, it is unknown why AF is self-terminating in certain individuals, which is called paroxysmal AF (PAF), and not in others. Within the context of biomedical signal analysis, predicting the onset of PAF with a reasonable advance has been a clinical challenge in recent years. By predicting arrhythmia onset, the loss of normal sinus rhythm could be addressed by means of preventive treatments, thus minimizing risks for the patients and improving their quality of life. Traditionally, the study of PAF onset has been undertaken through a variety of features characterizing P-wave spatial diversity from the standard 12-lead electrocardiogram (ECG) or from signal-averaged ECGs. However, the variability of features from the P-wave time course before PAF onset has not been exploited yet. This work introduces a new alternative to assess time diversity of the P-wave features from single-lead ECG recordings. Furthermore, the method is able to assess the risk of arrhythmia 1 h before its onset, which is a relevant advance in order to provide clinically useful PAF risk predictors. Results were in agreement with the electrophysiological changes taking place in the atria. Hence, P-wave features presented an increasing variability as PAF onset approximates, thus suggesting intermittently disturbed conduction in the atrial tissue. In addition, high PAF risk prediction accuracy, greater than 90%, has been reached in the two considered scenarios, i.e. discrimination between healthy individuals and PAF patients and between patients far from PAF and close to PAF onset. Nonetheless, more long-term studies have to be analyzed and validated in future works., This work was supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation and PPII11-0194-8121 and PII1C09-0036-3237 from Junta de Comunidades de Castilla La Mancha.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

  • Bernaldo de Quirós, Sandra
  • Merlo, Anna
  • Secades, Pablo
  • Zambrano, Iriana
  • Saenz de Santa María, Inés
  • Ugidos, Nerea
  • Suarez, Carlos
  • Chiara, Maria Dolores
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
Abstract: Background: Cytogenetic and gene expression analyses in head and neck squamous cell carcinomas (HNSCC) have allowed identification of genomic aberrations that may contribute to cancer pathophysiology. Nevertheless, the molecular consequences of numerous genetic alterations still remain unclear. Methods: To identify novel genes implicated in HNSCC pathogenesis, we analyzed the genomic alterations present in five HNSCC-derived cell lines by array CGH, and compared high level focal gene amplifications with gene expression levels to identify genes whose expression is directly impacted by these genetic events. Next, we knocked down TRPC6, one of the most highly amplified and over-expressed genes, to characterize the biological roles of TRPC6 in carcinogenesis. Finally, real time PCR was performed to determine TRPC6 gene dosage and mRNA levels in normal mucosa and human HNSCC tissues. Results: The data showed that the HNSCC-derived cell lines carry most of the recurrent genomic abnormalities previously described in primary tumors. High-level genomic amplifications were found at four chromosomal sites (11q21-q22.2, 18p11.31-p11.21, 19p13.2-p13.13, and 21q11) with associated gene expression changes in selective candidate genes suggesting that they may play an important role in the malignant behavior of HNSCC. One of the most dramatic alterations of gene transcription involved the TRPC6 gene (located at 11q21-q22.2) which has been recently implicated in tumour invasiveness. siRNA-induced knockdown of TRPC6 expression in HNSCC-derived cells dramatically inhibited HNSCC-cell invasion but did not significantly alter cell proliferation. Importantly, amplification and concomitant overexpression of TRPC6 was also found in HNSCC tumour samples. Conclusions: Altogether, these data show that TRPC6 is likely to be a target for 11q21-22.2 amplification that confers enhanced invasive behavior to HNSCC cells. Therefore, TRPC6 may be a promising therapeutic target in the treatment of HNSCC., This work was supported by Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [FIS PI11/929 to M.-D.C and C. S.]; Red Tematica de Investigacion Cooperativa en Cancer [RD12/0036/0015] Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF); and Obra Social CajAstur-Instituto Universitario de Oncologia del Principado de Asturias.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

  • Ajona, D.
  • Pajares, M. J.
  • Chiara, M. D.
  • Rodrigo, J. P.
  • Camps, C.
  • Suarez, C.
  • Bagan, J. V.
  • Montuenga, L. M.
  • Pio, R.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
OBJECTIVE: Complement C4d-containing fragments have been proposed as diagnostic markers for lung cancer. The purpose of this study was to evaluate the presence of C4d in oropharyngeal (OPSCC) and oral (OSCC) squamous cell carcinomas. SUBJECTS AND METHODS: C4d staining was analyzed by immunohistochemistry in 244 OPSCC surgical specimens. C4d levels were quantified by ELISA in resting saliva samples from 48 patients with oral leukoplakia and 62 with OSCC. Plasma samples from 21 patients with leukoplakia and 30 with oral carcinoma were also studied. RESULTS: C4d staining in OPSCC specimens was associated with nodal invasion (P = 0.001), histopathologic grade (P = 0.014), disease stage (P = 0.040), and focal-adhesion kinase expression (P < 0.001). No association was found between C4d and prognosis. Saliva C4d levels were higher in patients with oral cancer than in subjects with leukoplakia (0.07 +/- 0.07 vs 0.04 +/- 0.03 mu g ml(-1), P = 0.003). The area under the ROC curve was 0.63 (95%CI: 0.55-0.71). Salivary C4d levels in stage IV patients were higher than in patients with earlier stages (P = 0.028) and correlated with tumor size (P = 0.045). Plasma C4d levels also correlated with salivary C4d levels (P = 0.041), but differences between patients with oral cancer and subjects with leukoplakia were not significant (1.26 +/- 0.59 vs 1.09 +/- 0.39 mu g ml(-1), P = 0.232). CONCLUSION: C4d-containing fragments are detected in oral primary tumors and are increased in saliva from patients with OSCC., We thank Amaya Lavin for technical assistance. This work was supported by Foundation for Applied Medical Research (FIMA), Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0015, RD12/0036/0025, and RD12/0036/0040), and Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER, PI11/00618, PI13/00806, PI11/00929, and PI14/01686).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy

  • Herance, Jose Raul
  • Guitierrez Carcedo, Patricia
  • Pineda-Lucena, Antonio
  • Palomino-Schätzlein, M.
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
  • Navalón Oltra, Sergio|||0000-0001-8423-0759
[EN] Gold nanoparticles have high potential in the biomedical area, especially in disease diagnosis and treatment. The application of these nanoparticles requires the presence of stabilizers to avoid their agglomeration. Nowadays, there is a lack of reliable methods for characterising the effect of stabilised nanoparticles on biological systems. To this end, in this study, we apply an experimental approach based on nuclear magnetic resonance spectroscopy to study the effect of gold nanoparticles, stabilised with cerium oxide or chitosan, on a human cancer cell model. The results showed that both systems have a significant effect, even at non-toxic levels, on the cellular antioxidant system. However, although particles functionalised with chitosan exerted a strong effect on the aerobic respiration, nanoparticles stabilised with cerium oxide had a higher impact on the mechanisms associated with anaerobic energy production. Therefore, even though both systems contained similar gold nanoparticles, the presence of different stabilizers strongly influenced their mode of action and potential applications in biomedicine., This work was supported by the Carlos III Health Institute, the European Regional Development Fund (PI16/02064 and CP13/00252) and the Spanish Ministerio de Economia y Competitividad (SAF2014-53977-R, SAF2017-89229-R and RD12/0036/0025). In addition, JRH is a recipient of a contract from the Ministry of Health of the Carlos III Health Institute.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (S-s)-DS-ONJ

  • Gómez Jaramillo, María Laura
  • Cano-Cano, Fátima
  • Sánchez-Fernández, Elena M.
  • Ortiz Mellet, Carmen
  • García-Fernández, José M.
  • Alcalá, Martin
  • Álvarez-Gallego, Fabiola
  • Iturregui, Marta
  • González Montelongo, María del Carmen
  • Campos Caro, Antonio
  • Arroba Espinosa, Ana Isabel
  • Aguilar Diosdado, Manuel
Inflammatory processes play a central role in the pathogenesis of diabetic nephropathy (DN) in the early stages of the disease. The authors demonstrate that the glycolipid mimetic (Ss)-DS-ONJ is able to abolish inflammation via the induction of autophagy flux and provokes the inhibition of inflammasome complex in ex vivo and in vitro models, using adult kidney explants from BB rats. The contribution of (Ss)-DS-ONJ to reducing inflammatory events is mediated by the inhibition of classical stress kinase pathways and the blocking of inflammasome complex activation. The (Ss)-DS-ONJ treatment is able to inhibit the epithelial-to-mesenchymal transition (EMT) progression, but only when the IL18 levels are reduced by the treatment. These findings suggest that (Ss)-DS-ONJ could be a novel, and multifactorial treatment for DN.